Yeast phosphoglycerate mutase studied by site-directed mutagenesis by White, Malcolm F.
YEAST PHOSPHOGLYCERATE MUTASE STUDIED
BY SITE-DIRECTED MUTAGENESIS.
Malcolm F. White. BSc.Hons.
Thesis presented,









List of figures vi




1.2 The phosphoglycerate mutases 4
1.3 Distribution of mutases 4
1.4 Cofactor-independent phosphoglycerate mutase 5
1.5 Cofactor-dependent phosphoglycerate mutases 6
1.6 Evolution of phosphoglycerate mutases 8
1.6.1 The M and B isoenzymes 8
1.6.2 The E isoenzyme 10
1.6.3 Phylogeny 11
1.7 Reactions catalysed by phosphoglycerate mutases 12
1.7.1 Investigation of the reaction mechanism 12
1.8 Structure of phosphoglycerate mutase 16
1.8.1 Primary structure 16
1.8.2 Tertiary structure 16
1.8.3 The active site 18
1.9 Proposed mechanism for phosphoglycerate mutases 25
1.9.1 Mutase reaction 25
1.9.2 Phosphatase reaction 27
1.9.3 Synthase reaction 28
1.10 The synthase/mutase relationship 30
1.10.1 Kinetic constants 31
1.10.2 Rates of phospho-transfer 32
1.10.3 Molecular basis 33
1.11 The C-terminal tail 38
1.12 Aim of project 40
1.13 Strategy of project 41




2.1.3 Growth media 44
2.1.4 Radiochemicals 44





2.2.1 Experimental precautions 47
2.2.2 Standard experimental techniques 47
2.2.3 Radiolabelling of DNA by random priming 48
2.2.4 Preparation and use of oligonucleotides 50
2.2.5 Southern blotting 52
2.2.6 Slot-blotting 53
2.2.7 Heparin hybridization 54
2.2.8 DNA sequencing 55
2.2.9 Site-directed mutagenesis 55
2.2.10 Growth of yeast 56
2.2.11 Transformation of yeast 59
2.2.11.1 Spheroplast transformation 59
2.2.11.2 Lithium acetate transformation 61
2.2.11.3 Analysis of yeast transformants 62
2.2.12 Purification of phosphoglycerate mutase 64
2.2.12.1 Lysis and ammonium sulphate cut 64
2.2.12.2 Affinity chromatography 65
2.2.12.3 Determination of protein concentration 68
2.2.12.4 Assay of phosphoglycerate mutase 68
2.2.12.5 Protease inhibitors 69
2.2.12.6 Denaturing gel electrophoresis 70
2.2.13 Estimation of the kinetic parameters 70
2.2.13.1 Michaelis constants for 3-PGA & 2,3-BPGA 70
2.2.13.2 Michaelis constant for 2-PGA 72
2.2.13.3 Synthase assay 72
2.2.13.4 Phosphatase assay 7 6


































Localisation and sequencing of GEM gene
3.1 Restriction mapping and location of GFM gene
3.2 Subcloning and sequencing of the GPM gene
3.3 Features of the DNA sequence
3.4 Features of the protein sequence
Replacement of the GPM gene
4.1 Why gene replacement?
4.2 Strategy for gene replacement
Design, construction and expression of mutant GFM's
5.1 Design and construction of the mutants
5.2 Screening for the mutants
5.3 Subcloning of the mutants
5.4 Transformation of DBYgpm-
5.5 Analysis of yeast transformants
5.6 Expression levels of phosphoglycerate mutases
5.7 Growth characteristics
Purification of phosphoglycerate mutases
6.1 Background
6.2 Specific considerations
6.3 Purification of wild-type
6.4 Purification of K246G
6.5 Purification of SllG
Kinetic characterisation
7.1 Km for 3-phosphoglycerate
7.2 Km for 2-phosphoglycerate




7.7 Wild-type phosphoglycerate mutase
7.8 K246G phosphoglycerate mutase
7.9 SllG phosphoglycerate mutase
General discussion and future work
9. Summary
10. References
Appendix A: Published paper
DECLARATION
I hereby declare that this thesis has been composed by me, that it has
not been accepted in any previous application for a degree and that




Many people have contributed to this thesis and deserve my sincere
thanks:
I should like to thank my supervisor, Dr Linda Fothergill-Gilmore, for
her enthusiastic help and guidance thoughout the course of this
project.
Also, the members of the Department of Biochemistry, and especially
the denizens of lab 327, for creating such a pleasant study
environment.
Professor Dan Fraenkel, for his kind gift of the plasmid YEP13.GPM.
The Science and Engineering Research Council for financial support.
My parents, Eric and Betty, for their love and support through all my
student years.





















































































































Asp - Aspartic acid

















Asx - Aspartic acid or asparagine
Glx - Glutamic acid or glutamine
iv
(3) Proteins
BSA - Bovine serum albumin
GAPDH - Glyceraldehyde-3-phosphate dehydrogenase
LDH - Lactate dehydrogenase
PGK - Phosphoglycerate kinase




1.1 Pathway of glycolysis 3
1.2 Reactions catalysed by phosphoglycerate mutases 13
1.3 Alignment of mutase sequences 17
1.4 Yeast phosphoglycerate mutase tetramer 19
1.5 Yeast phosphoglycerate mutase subunit 20
1.6 Yeast phosphoglycerate mutase active site 21
1.7 Binding of cofactor and substrates 23-24
1.8 Proposed reaction sequence 26
1.9 Comparison of mutases and synthases 35
1.10 Active site of yeast phosphoglycerate mutase 36
1.11 Active site of the synthase enzymes 37
2.1 Eckstein method of mutagenesis 57
2.2 Elution profile during purification 67
2.3 Standard curve for synthase assay 75
2.4 Standard curve for phosphatase assay 77
3.1a Restriction mapping YEP13.GPM 81
3.lb Localisation of GPM gene 82
3.lc Restriction map of GPM gene locus 82
3.2 Sequencing strategy 84
3.3 Nucleotide and derived protein sequence of GPM gene 86
3.4 Codon bias of GPM gene 88
4.1 Outline of gene replacement 94
4.2 Plasmid construction for gene replacement 96
4.3 Genomic maps of DBY747 and DBYgpm- 97
4.4 Southern blot analysis of gene replacement 99
5.1 DNA sequence analysis of mutant GPM genes 104
5.2 Subcloning mutant GPM genes 106
5.3 Slot-blot analysis of mutant GPM genes 112
5.4 SDS-PAGE analysis of protein expression levels 114
5.5 Growth curves of transformed DBYgpm- 117
6.1 SDS-PAGE analysis of enzyme purification 123
7.1 Hanes plots of Km's for 3-PGA 133
7.2 Hanes plots of Km's for 2-PGA 134




1.1 Physical properties of phosphoglycerate mutases 9
1.2 Comparison of mutase and synthase activities 31
1.3 Rates of phosphorylation of B and E isoenzymes 32
5.1 Results of spheroplast transformation 110
6.1 Purification of wild-type phosphoglycerate mutase 124
6.2 Purification of K246G phosphoglycerate mutase 124
6.3 Purification of S11G phosphoglycerate mutase 126
7.1 Km's for 3-PGA 130
7.2 Km's for 2-PGA 131
7.3 Km's for 2,3-BPGA 131
7.4 Catalytic constants for mutase activity 136
7.5 Catalytic constants for synthase activity 137
7.6 Catalytic constants for phosphatase activity 138.
vii
ABSTRACT
The enzyme phosphoglycerate mutase (EC 5.4.2.1) catalyses the
interconversion of 2-phosphoglycerate and 3-phosphoglycerate in
the glycolytic/gluconeogenic pathways. It also possesses minor
2,3-bisphosphoglycerate synthase and phosphatase activities. The
enzyme from Saccharomyces cerevisiae, whose amino acid sequence and
high resolution crystal structure are known, has been particularly
well characterised. A detailed catalytic mechanism has been proposed,
based on structural and kinetic evidence. The enzyme has a flexible
C-terminal 'tail', which is essential for its activity. The closely
related enzyme bisphosphoglycerate synthase (EC 5.4.2.4/3.1.3.13),
which is present in vertebrate erythrocytes, catalyses the same three
reactions, but has a much lower mutase aictivity and a higher synthase
activity. The two enzymes share about 50% sequence identity. The aim
of this project was to probe the molecular basis for the
mutase/synthase relationship and the function of the C-terminal tail
using protein engineering of the S.cerevisiae enzyme.
The gene encoding S.cerevisiae phosphoglycerate mutase (GFM) was
located and sequenced. A strain of yeast, entitled DBYgpm-, was
constructed in which the chromosomal copy of the GPM gene has been
deleted. Two mutant forms of the enzyme were designed and
constructed, expressed in DBYgpm-, purified and kinetically
characterised. The first, in which the C-terminal lysine had been
replaced by a glycine (K246G), was not significantly different
kinetically from the wild-type enzyme. This suggests that the C-
terminal lysine plays no major part in catalysis. In the second, an
active site serine had been replaced by a glycine (S11G). In the
S.cerevisiae enzyme this residue is thought to be important as a
phospho-ligand, whereas in the synthase enzyme it is a glycine and
could play no part in ligand binding. For the S11G mutant, the
affinity for 2,3-bisphosphoglycerate was lowered tenfold and the
mutase activity was decreased by 99.5% whilst the synthase activity-
was unaffected. These observations confirm the important role of
serine 11 in the binding of 2,3-bisphosphoglyrcerate and in the mutase




The pathway of glycolysis (figure 1.1) is an ancient one, and is
found, at least in part, in all living organisms. The glycolytic
enzymes exist at relatively high levels in most cells. They have
been extensively characterized both structurally and kinetically.
The amino acid sequences of the enzymes have been determined from a
number of different sources, and are found to be amongst the most
highly conserved proteins (Fothergill-Gilmore, 1986). The crystal
structures of most have been determined, and share a common
structural motif - a core of 6-strands surrounded by a-helices.
The advent of recombinant DNA technology has added a fresh impetus
to the study of this pathway. The development of a simple method
for DNA sequencing has led to many more protein sequences being
determined. More recently, the development of site-directed
mutagenesis has allowed ideas on the molecular basis for activity
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Figure 1.1. The pathway of glycolysis. The reaction catalysed by
phosphoglycerate mutase is indicated.
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1.2 The phosphoglycerate mutases
Phosphoglycerate mutase catalyses the interconversion of 2- and 3-
phosphoglycerate in the lower half of the glycolytic pathway. The
enzyme was first identified over 50 years ago (Meyerhof and
Kiessling, 1935), and has since been detected in every organism so
far studied, with the possible exception of certain thermophilic
archaebacteria (Budgen and Danson, 1986). Two main types of mutase
are known - one which requires the cofactor 2,3-bisphosphoglycerate
(2,3-BPGA) for activity and is thus termed 'cofactor-dependent';
and the other, which has no requirement for 2,3-BPGA and is termed
'cofactor-independent'.
1.3 Distribution of cofactor-dependent and cofactor-independent
mutases
Cofactor-independent mutases were at first thought to be confined
to higher plants, however the subsequent extensive screening of
over 80 species revealed a much more complex distribution. Thus
plants, filamentous fungi, invertebrates such as sponges, sea-
urchins and spiders and the Gram positive Bacillus bacteria have
been shown to possess cofactor-independent mutases (Price et al. ,
1983; Carreras et al., 1982; Singh and Setlow, 1979; Watabe and
Freese, 1979) whilst cofactor-dependent enzymes are found in
vertebrates, certain invertebrates such as mussels, earthworms and
insects (Carreras et al., 1982), fungi such as Saccharomyces
cerevisiae and Schizosaccharomyces pombe (Price et al. , 1983) and
Gram negative bacteria such as Escherichia coli (D'Alessio and
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Josse, 1971) and Zymomonas mobilis (Pawluk et al., 1986).
Cofactor-dependent phosphoglycerate mutase can be distinguished
from the cofactor-independent form by its ability to bind to
cibacron blue-Sepharose and to be eluted by the cofactor 2,3-BPGA
(Price and Stevens, 1983). If one accepts this property as
diagnostic of cofactor-dependent enzymes, then studies of Gram
positive lactic acid bacteria by (Kawai et al., 1981) uncover a
further layer of complexity in the distribution of the two enzymes.
Using the dye-binding/elution test, they found that four
Lactobacillus species, two Streptococcus species and two
Pediococcus species possessed cofactor-independent enzymes, whilst
four Lactobacillus species had cofactor-dependent enzymes.
Furthermore, in the species Leuconostoc mesenteroides, two strains
tested were cofactor-dependent and two cofactor-independent.
The complexity of the distribution of the cofactor-dependent and
cofactor-independent enzymes suggests that the two genes which code
for them were both present early in evolution and have been
inherited in a haphazard fashion.
1.4 Cofactor-independent phosphoglycerate mutase
The cofactor-independent mutases are inherently unstable enzymes
and have proved recalcitrant to purification. Consequently
comparatively little is known about this class of the enzyme. A
cofactor-independent mutase was first identified in wheat-germ (Ito
and Grisolia, 1959) and has since been noted in a number of
organisms. The enzyme appears to be a monomer, Mr about 60,000,
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with a pH optimum around 8.5 (Fothergill-Gilmore and Watson, 1989).
Isotope exchange experiments have shown that it is capable of
transferring a phospho-group directly to glycerate at the active
site (Breathnach and Knowles, 1977). Recently two distinct
isoenzymes have been identified in certain higher plants,
corresponding to cytosolic and plastid forms of the enzyme. The
cytosolic form is more abundant and has a higher affinity for
substrate (Botha and Dennis, 1986). The enzyme from Bacillus
species is a cofactor-independent monomer, with a similar Mr , but
differs from all other mutases in exhibiting an absolute
requirement for Mn2 * (Singh and Setlow, 1979; Watabe and Freese,
1979). A lack of any protein sequence information limits the
further analysis of the cofactor-independent enzyme.
1.5 Cofactor-dependent phosphoglycerate mutases
The cofactor-dependent mutases have proved much easier to purify,
and thus have been much more extensively characterised. The enzyme
exhibits a varied quaternary structure: tetrameric in yeast such as
S.cerevisiae; dimeric in vertebrates and Gram negative bacteria
such as E.coli (D'Alessio and Josse, 1971) and Z.mobilis (Pawluk et
al., 1986) and in some Gram positive bacteria such as Leuconostoc
dextranicum (Kawai et al., 1983); and monomeric in the fission
yeast S.pombe (Price et al., 1985a). The subunit Mr is commonly in
the range 27,000-30,000, although the S.pombe enzyme appears to be
smaller at 23,000 (for a review, see Fothergill-Gilmore and Watson,
1989) .
6
A great deal of effort has gone into the study of all aspects of
cofactor-dependent phosphoglycerate mutases, particularly those
from vertebrates and S.cerevisiae. The remainder of this
introduction will concentrate on aspects of the structure,
activities, molecular mechanism and evolution of the cofactor-
dependent mutases.
1.6 Evolution of phosphoglycerate mutases
It is apparent that two quite distinct enzymes with
phosphoglycerate mutase activity exist. These two enzymes are
probably not homologous and may both have existed in an ancestral
organism; one or the other being lost in the course of evolution to
give the complex distribution we see today (Fothergill-Gilmore and
Watson, 1989).
1.6.1 The M and B isoenzymes
The gene inherited by early vertebrates, coding for a cofactor-
dependent enzyme, appears to have undergone a series of gene
duplication events. Fish and all higher vertebrates (excluding
birds) possess two isoenzymes of differing mobility in cellulose
acetate electrophoresis (Mezquita and Carreras, 1981). These have
been termed the B (brain) and M (muscle) isoenzymes, the B form
being the more mobile of the two. In mammals, the B form is
present in most tissues excluding skeletal muscle, whilst the M
form is only found in cardiac and skeletal muscle. In tissues
where both isoenzymes are expressed, for example in the heart, MB
heterodimers are observed (Bartrons and Carreras, 1982). The
electrophoretic mobility, heat stability and sensitivity to -SH
group modification of the isoenzymes from a variety of species have
been investigated, and are summarised in table 1.1.
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Table 1.1. Physical properties of vertebrate phosphoglycerate
mutases
All data and experimental details can be found in (Mezquita et
al., 1981). Isoenzymes are designated 'M' or 'B' according to
their observed electrophoretic mobility, 'nd' indicates a property
was not determined.
organism isoenzyme sensitive sensitive to electrophor.
to heat -SH modn. mobility
mammals M - + slow
B + - fast
reptiles M - + slow
B + - fast
pigeon B + - fast
chicken B + + fast
amphibians M nd + slow
B nd + fast
fish M nd + slow
B nd + fast
The two isoenzymes share around 80% sequence identity in humans
(Sakoda et al., 1988) and display very similar kinetic properties
(Berrocal and Carreras, 1982). The differing sensitivity to -SH
group modifying agents can be explained by the active site residue
20, which is a cysteine in the M isoenzyme and a threonine in the B
isoenzyme. Interestingly, the enzymes present in pigeon and
chicken differ in their sensitivity to -SH modification, presumably
for the same reason. In the lower vertebrates, amphibians and
fish, both the M and B isoenzymes are sensitive, although this is
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not the case for the enzyme from S.cerevisiae, which has no
cysteine residues. Can we say which is the ancestral form of the
enzyme? The B isoenzyme appears to be more widely expressed in
vertebrate tissues, indeed the electrophoretic evidence suggests
that birds appear to possess only the B isoenzyme (Mezquita and
Cameras, 1981). Also, analysis of human genomic DNA has shown
that several copies of the B gene exist, possibly in the form of
processed pseudogenes (Sakoda et al., 1988). This is perhaps
evidence that the M gene may have arisen from a duplication of the
B gene, the B form of the enzyme being ancestral.
1.6.2 The E isoenzyme
Another gene duplication event gave rise to a third isoenzyme - E
(erythrocyte). The , E isoenzyme is expressed mainly in the
erythrocytes of most vertebrates, probably from amphibia onwards,
where it is responsible for the synthesis of 2,3-BPGA; a potent
effector of haemoglobin. This role for 2,3-BPGA probably first
arose in amphibia, thus the evolution of this isoenzyme is closely
linked with the evolution of haemoglobin as an oxygen transporter
(Fothergill-Gilmore and Watson, 1989). The E isoenzyme is also
expressed at low levels in other tissues, where it exists in the
form of BE and ME heterodimers (Tauler et al., 1986; Tauler and
Cameras, 1987). This isoenzyme probably also arose from
duplication of the B gene, as the human B and E genes share some
limited sequence identity in their downstream non-coding regions
(Sakoda et al. , 1988). The sequences of three E isoenzymes are
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known - from human, rabbit and mouse. They are very highly
conserved (90%), and have about 50% identity with the yeast, and
human M and B enzymes.
1.6.3 Phytogeny
What was the order of appearance of the three isoenzymes M, B and
E? As we have seen, there is reasonable evidence that the B form
corresponds to the ancestral one, the M and E isoenzymes arising
from duplications of the B gene followed by divergent evolution.
There are two schools of thought over the order of appearance of
the M and E isoenzymes. One, based on primary structure
information, suggests that the B and M isoenzymes, being 80%
identical in amino acid sequence, must have diverged later than the
E isoenzyme, which is only about 50% identical to either the B or M
isoenzyme (Fothergill-Gilmore and Watson, 1989). The other, based
primarily on the isoenzyme studies and on the supposed link
between the E isoenzyme and haemoglobin discussed above, suggests
that the B/M divergence predates the B/E divergence. Whilst there
is not enough evidence to reach a firm conclusion, the latter
explanation appears more likely at present. The sequence
information does not necessarily conflict with this theory as one
can consider the E isoenzyme to be functionally distinct from the M
and B forms, which appear to have the same role in different
tissues and whose divergence may therefore have been more
constrained in the course of evolution.
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1.7 Reactions catalysed by phosphoglycerate mutases
Phosphoglycerate mutases catalyse three reactions : the
interconversion of 2- and 3-phosphoglycerate and the synthesis and
degradation of 2,3-bisphosphoglycerate (fig. 1.2). These reactions
are commonly called the mutase, synthase and phosphatase activities
respectively. Originally it was envisaged that three different
enzymes catalysed these three reactions, however multiple
activities consistently co-purified from a variety of sources (Rose
and Whalen, 1973; Rosa et al. , 1975). It was then suggested that
all three reactions could be catalysed by a single polypeptide in
human erythrocytes and yeast (Sasaki et al., 1975,76). The
ancestral enzyme, which corresponds to the yeast and vertebrate M
and B enzymes found today, has a very high ratio of mutase :
synthase activities, and is commonly denoted 'phosphoglycerate
mutase' or 'monophosphoglycerate mutase'. The E isoenzyme, which
probably evolved more recently, has a ratio of mutase : synthase
activities which approaches parity, and is usually termed
'bisphosphoglycerate mutase' or 'bisphosphoglycerate synthase'.
The relationship between these two forms of the enzyme is discussed
in more detail in section 1.10.
1.7.1 Investigation of the reaction mechanism
Early experiments demonstrated that the mutase activity of rabbit
M-type phosphoglycerate mutase was dependent on catalytic amounts

























Figure 1.2. The three reactions catalysed by cofactor-dependent
phosphoglycerate mutases.
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subsequently shown that this cofactor was required only once in
every 100 catalytic cycles (Grisolia and Cleland, 1968). In one of
the first experiments to use a radioactive tracer, it was shown
that after a 30 min incubation of rabbit M-type phosphoglycerate
mutase with 32P-labelled 2-phosphoglycerate, the radioactive label
could be detected in 3-phosphoglycerate, 2-phosphoglycerate and
2,3-bisphosphoglycerate (Sutherland et al., 1949b). This important
experiment demonstrated that all three ligands bound at the active
site of the enzyme, and that phospho-transfer could occur between
them.
Two possibilities existed for the nature of the phospho-transfer
event catalysed by phosphoglycerate mutase. One school of thought
predicted the existence of a ternary complex at the active site,
with the direct transfer of a phospho-group from 2,3-
bisphosphoglycerate to a monophosphoglycerate (Chiba et al., 1970).
The other postulated a ping-pong mechanism involving a phospho-
enzyme intermediate (Grisolia and Cleland, 1968). Attempts to
clarify this situation by kinetic analysis led to conflicting
results, but the development of an induced transport test based on
flux kinetics proved conclusively that yeast, rabbit M-type and pig
B-type phosphoglycerate mutase all functioned by a ping-pong,
phosphoenzyme mechanism (Britton et al., 1972a,b, 1973). This
mechanism was later found to be consistent with the rates of
phosphorylation of the chicken B-type and horse E-type enzymes by
2,3-bisphosphoglycerate. Using a stopped-flow technique, Rose and
14
Dube (1976) demonstrated that these enzymes were phosphorylated by
the cofactor at rates consistent with the overall rates of the
mutase reactions which they catalysed (see section 1.10.2).
Assuming that a phospho-enzyme was formed during catalysis, which
residue was phosphorylated? Rose (1970,71) identified a histidine
residue as becoming phosphorylated after incubation of the yeast or
rabbit M-type enzymes with 32P-labelled 2,3-bisphosphoglycerate.
Subsequently, the isolation of phospho-peptides from the yeast and
human and horse E-type enzymes enabled the identification of the
His-8 residue (yeast numbering) as the phosphohistidine (Han and
Rose, 1979; Hass et al., 1980).
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1.8 Structure of phosphoglycerate mutase
1.8.1 Primary structure
The first primary structure information for phosphoglycerate
mutases came from the determination of the amino acid sequences of
the yeast and human E-type enzymes by protein sequencing'
(Fothergill and Harkins, 1982; Haggarty et al., 1983). The two
enzymes were shown to share 47% identity, emphasising their close
evolutionary relationship. The advent of recombinant DNA
technology, and specifically the development of methods for the
isolation and rapid DNA sequencing of chromosomal and cDNA copies
of specific genes, has recently led to the correction of the yeast
and human E enzyme sequences (White and Fothergill-Gilmore, 1988;
Joulin et al., 1986), and to the determination of the human M and B
and rabbit and mouse E isoenzyme sequences.(Shanske et al., 1987;
Blouquit et al., 1988; Yanaga et al., 1986; LeBoulch et al., 1988).
The sequences are compared in figure 1.3, and show obvious
homology. As we shall see, the availablity of sequence information
for a range of phosphoglycerate mutases has been a great aid in
elucidating the molecular basis for the activities of the enzymes.
1.8.2 Tertiary structure
The high resolution crystal structure of yeast phosphoglycerate
mutase has been determined (Winn et al., 1981). The protein exists
as a tetramer, composed of four identical subunits, with almost
16
1 58
Y P—KLVLVRHGQSEWNEKNLFTGWVDVKLSAK GQQEAARAGELLK EK K VYPDVLYTSK LS
HM ATHRLVMVRHGESTWNQENRFCGWFDAELSEKGTEEAKRGAKAIK DAK MEFDICYTSVLK
HE AAYKLVLIRHGESAWNLENRFSGWYDADLSPAGHEEAK RGGQALRDAGYEFDICFTSVQK
HE SK YK LIMLRHGEBAWNK ENRFCSWVDQK LNSEGMEEARNCGKQLK ALNFEFDLVFTSVLN
ME SK HK L11LRHGEGKWNKENRFCSWVDQK LNNQGLEEARNCGRQLKALNFEFDLVFTSILN
RE SK YKLIMLRHGEGAWNKENRFCSWVDQKLNSEGMEEARNCGKQLKALNFEFDLVFTSVLN
* * . + + . * * . +. + . * + *. .** .
59 118
Y RAIQTANIALEKADRLWIPVNRSWRLNERHYGDLQGK DK AETLKK FGEEKFNTYRRSFDV
HM RAIRTLWAILDGTDQMWLPVVRTWRLNERHYGGLTGLNKAETAAK HGEEQVKIWRFSFDT




*.%.* *. .. +.+* ..+#***»***.* * .... . +*.. . .*#♦...
119 174
Y PPPPI DASSF'FSQK —GDERYK Y—VDPNVLPETESLALVIDRLLPYWQDVI AK DLLSGK
HM PPPPMDEKHPYYNSISK ERRYA—GLK PGELPTCESLKDTIARALPFWNEEIVPQIK AGK
HE PPPPMEPDHPFYSNISK DRRYA—DLTEDQLPSCESLK DTIARALPFWNEEIVPQIK ESK
HE TF'PP I EESHF'YYQE IYNDRRYK VCDVPLDQLPRSESLK DVLERLLPYWNERI APEVLRGK
ME TPPPIEESHPIFHEIYSDRRYKVCDVPLDQLPRSESLK DVLERLLPYWKERIAPEILK GK
RE TPPP I EESHPYYHEI YSDRRYRVCDVF'LDQLF'RSESLK DVLERLLPYWNER I APEVLRGK
„###.. . * . . *♦ . . ** +#* ...* **.#.. *. .. **
175 233
Y TVMIAAHGNSLRGLVK HLEG LSDAD I AK LNIPTGI PLVFELDENLK PSK PSYYL—DF'EAA
HM RVLIAAHGNSLRGIVK HLEGMSDQAIMELNLPTGIPIVYELNKELK PTKPMQFLGDEETV
HE RVLIAAHGNSLRGIVK HLEGLSEEAIMELNLPTGIPIVYELDKNLKPIK PMQFLGDEETV
HE TILISAHGNSSRALLK HLEGISDED11NITLPTGVPILLELDENLRAVGPHQFLGDQEAI
ME SILISAHGNSSRALLK HLEGISDED11NITLPTGVPILLELDENLRAVGPHQFLGNQEAI
RE TVLISAHGNSSRALLK HLEG I SDED 11NI TLPTGVP I LLELDENLRAVGF'HQFLGDQEA I





HE QAAIKK VEDQGK VK QAK K
ME QAAIKK VDDQGK VK QGK Q
RE QAAIKK VENQGK VK RAEK
*..***
Figure 1.3. Alignment of the six known amino acid sequences of
phosphoglycerate mutases (Y- yeast; HM- human muscle; HB- human
brain; HE- human erythrocyte; ME- mouse erythrocyte; RE- rabbit
erythrocyte). Residues identical in all six sequences are
indicated by an asterisk and partially conserved residues by a full
stop. The numbering corresponds to the yeast sequence. The
sequence alignment was generated by the multi-alignment progam
C-LUSTAL developed by Higgins and Sharp (1988) .
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exact 222 symmetry (fig. 1.4). The polypeptide backbone folds into
a single domain consisting of a core of B-sheets surrounded by
a-helices; a structural motif common to many dehydrogenases and
kinases (Campbell et al., 1974). The active site, located by
soaking crystals in the substrate 3-phosphoglycerate, is formed
entirely by the residues of one subunit (figures 1.5 & 1.6). The
unligated, native form of the enzyme has two sulphate ions at the
active site, and their positions are presumed to correspond to
those of the phospho-groups of the bound ligands. The C-terminal
'tail' of the enzyme, as deduced from the protein sequence, does
not contribute to the electron density map, and is therefore
considered to be flexible under the conditions in which the enzyme
was crystallised.
1.8.3 The active site
The active site of the enzyme is shown in fig. 1.6. Histidine 8,
which has been shown to become phosphorylated during the catalytic
cycle, is present in a position close to the first sulphate ion
(SI). This probably represents the position of the transferrable
phospho-group of bound 2,3- or 1,3-bisphosphoglycerate. Parallel
to His-8, and only 0.4nm distant, lies His-181. This residue is in
a suitable position to act as a proton donor/acceptor during
phospho-transfer. Both histidines are conserved in all mutases
sequenced so far. The transferrable phospho-group would be in a
suitable position to form hydrogen bonds with Ser-11 and Thr-20 in
the yeast enzyme, and the expected third phospho-ligand may be
provided by one of the two C-terminal lysine residues (see section
18
Figure 1.4. The structure of the yeast phosphoglycerate mutase
tetramer. The a-helices are indicated by the red cylinders, and
the B-strands by the blue arrows. Green arrows correspond to
portions of the polypeptide chain eonecting elements of secondary
structure. The four active sites are shown by space-filling models
of 3-phosphoglycerate as located by crystal soaking experiments.
This drawing and figure 1.5 appear courtesy of J. Littlechild and
H. Watson of Bristol University.
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Figure 1.5. The yeast phosphoglycerate mutase subunit. The
elements of secondary structure and the active site are indicated
as for figure 1.4. The a-helices are labelled A1-A3 and A5-A7,
and the B-strands are labelled B1-B6. A portion of the polypeptide
chain including helix A4 has been removed to reveal the active
site. The a-carbon positions of the residues bordering the
active site are indicated by numbered circles. The C-terminal tail
has been represented by the following symbols - open circles
represent ala and gly residues, closed circles represent residues
with larger side chains and stars represent the two C-terminal
lysine residues.
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Figure 1.6. The active site of yeast phosphoglycerate mutase. The
side-chains bordering the active site are labelled. The two
sulphate ions found at the active site of the native, unliganded
form of the crystal are drawn and are labelled SI and S2. This
diagram is reproduced from (Fothergill-Gilmore and Watson, 1989)
with the permission of the authors.
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1.11). The second, non-transferrable phospho-group (position S2)
probably interacts with the positive dipole associated with the
amino-terminus of helix 7. Arg-59, which is also conserved in all
mutases, is in a suitable position to form a salt bridge with the
carboxyl group of the bound ligands.
Yeast phosphoglycerate mutase has a high affinity for the cofactor
2,3-bisphosphoglycerate; the Km has been estimated as 0.8jjM (Chiba
et al., 1970). Model-building has shown that 2,3-
bisphosphoglycerate can bind at the active site in either of two
orientations, with the positions of the 2- and 3- phospho-groups
reversed (fig. 1.7a; Fothergill-Gilmore and Watson, 1989). The
implications of this observation for the reaction mechanism of the
enzyme will be discussed in the following section. As shown in
figures 1.7b and c, 3-phosphoglycerate and 2-phosphoglycerate
probably bind to the phospho-enzyme with their phospho-group
occupying the position of the second sulphate ion (S2) in the
crystal structure. The enzyme must be flexible enough to
accommodate the binding of each of these species. The Michaelis
constants of yeast phosphoglycerate mutase for 2- and 3-
phosphoglycerate have been estimated as < lOOpM and 71 OpM
respectively (Rodwell et al., 1957; McAleese et al., 1987). The
lower Km observed for 2-phosphoglycerate indicates that it can be
more tightly bound than 3-phosphoglycerate.
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Figure 1.7. The proposed binding of eofactor and substrates at the
active site of phosphoglycerate mutase. The positions of His-8 and
His-181 are indicated, with the hatched atoms corresponding to the
ring nitrogens, (a) 2,3-bisphosphoglycerate is shown bound with the
3-phospho group occupying the SI or 'His-8' position and the 2-
phospho group in the S2 or 'helix dipole' position. The carboxyl
group is in a suitable position to interact with Arg-59. The
dashed lines indicate electron density corresponding to ions bound
at the active site of the unliganded enzyme, (b) 2-phosphoglycerate
is shown bound at the active site of the catalytically-competent
phosphoenzyme. The filled-in atom represents the proton that is
abstracted or donated by His-181 during catalysis. (c) 3-
phosphoglycerate shown in its bound position at the active site.
The small differences in the positions of the carboxyl groups of 2-
phosphoglycerate and 3-phosphoglycerate may account for the
different affinities with which they are bound by the enzyme. This
figure is reproduced from (Fothergill-Gilmore and Watson, 1989)
with the permission of the authors.
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1.9 Proposed mechanism for phosphoglycerate mutases
Based on the extensive structural, kinetic and chemical analyses of
phosphoglycerate mutases, a common reaction mechanism has been
proposed, which can accommodate the mutase, synthase and
phosphatase activities observed for the enzymes (Fothergill-Gilmore
and Watson, 1989). The proposed reaction sequences are summarised
schematically in fig. 1.8. The residue numbering used here refers
to the yeast enzyme, the structure of which is best characterised.
1.9.1 Mutase reaction
The unphosphorylated form of the enzyme is labelled 'i' in fig.
1.8. Priming of the mutase reaction would occur when 2,3-
bisphosphoglycerate bound to the unphosphorylated enzyme, in either
of two orientations. In 'd' the 2-phospho group is in the
transferrable position close to His-8, and probably forms hydrogen
bonds with Ser-11, Thr-20 and one of the C-terminal lysines. The
3-phospho group is interacting with the positive charge associated
with the dipole at the amino terminus of helix 7, and the carboxyl
group forms a salt-bridge with Arg-59. In 'e' the positions of the
phospho-groups are reversed.
Phospho-transfer to His-8 could then occur, with the donation of a
proton by His-181, giving rise to 'c' and 'f' in fig. 1.8. The 2-
phosphoglycerate or 3-phosphoglycerate formed would then be
released, giving rise to the phosphorylated, catalytically









Figure 1.8. Proposed reaction sequence of cofactor-dependent
phosphoglycerate mutases. The upper part of each diagram
represents the active site of the enzyme with the triangle
correponding to His-8. The numerals 1, 2 and 3 label the carbon
atoms of glycerate. The large circles represent phospho-groups,
and the small circles oxygen atoms of hydroxyl or carboxyl groups.
Symbols (IUPAC-IUB Commission on Biochemical Nomenclature, 1978):
Gri-2,3-P2, 2,3-bisphosphoglvcerate; Gri-1,3-P2, 1,3-
bisphosphoglycerate; Gri-2-P, 2-phosphoglycerate; Gri-3-P, 3-
phosphoglycerate. This figure is reproduced from (Fothergill-
Gilmore and Watson, 1989) with the permission of the authors.
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catalysis would begin when either 3-phosphoglycerate (for
glycolysis) or 2-phosphoglycerate (for gluconeogenesis) bound to
the active site of the phospho-enzyme. Phospho-transfer from the
enzyme to the substrate would produce 2,3-bisphosphoglycerate at
the active site ('d' and 'e' in fig. 1.8). The proposed mechanism
then requires that the cofactor re-orientates in the active site in
order to allow the transfer of the phospho-group introduced by the
substrate to the enzyme (the interconversion of 'd' and 'e' in fig.
1.8). Modelling studies have indicated that the size and shape of
the active site pocket are such as to make this possible, assuming
that the 2,3-bisphosphoglycerate could move away slightly from His-
8 and His-181. During this reorientation, the cofactor could be
retained in the active site by charge attraction and by the action
of the C-terminal tail (Fothergill-Gilmore and Watson, 1989). Once
reorientation had taken place, phospho-transfer would result in the
formation of a mono-phosphorylated product, which could be
released, and a phospho-enzyme, which could take part in another
round of catalysis ('h' and 'g' in fig. 1.8).
1.9.2 Phosphatase reaction
The low phosphatase activity observed for phosphoglycerate mutases
probably arises from the occasional hydrolysis of the phospho-
enzyme, which has been calculated sis having a half-life of 1-2 min
(Britton et al., 1972b). The existence of a low rate of
dephosphorylation of the enzyme gives rise to a requirement for a
phospho-donor; in other words it is responsible for the 'cofactor
dependence' of the enzyme. Phosphatase activity can be stimulated
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by many anions, and particularly by the two-carbon substrate
analogue 2-phosphoglycollate. It has been suggested that this
analogue is sufficiently similar to the substrates to bind at the
active site along with a molecule of water, enticing the C-terminal
tail into the active site and promoting the transfer of the enzyme-
bound phospho-group to the water molecule (Fothergill-Gilmore and
Watson, 1989). In support of this theory, it has been observed
that the 'tail-less' form of yeast phosphoglycerate mutase retains
a basal phosphatase activity which can no longer be stimulated by
2-phosphoglycollate (Sasaki et al., 1971; see section 1.11).
1.9.3 Synthase reaction
The 2,3-bisphosphoglycerate synthase activity of phosphoglycerate
mutase would be initiated when the substrate 1,3-
bisphosphoglycerate bound to the active site of the
unphosphorylated enzyme ('a' in fig. 1.8). It is likely that the
substrate would bind so that the phospho-group on carbon 1 was in a
suitable position for transfer to the enzyme, and that the 3-
phospho group was in the helix dipole position. In this
orientation Arg-59 would not be involved in binding the substrate.
Once phospho-transfer had occurred ('b' in fig. 1.8), the
negatively charged carboxyl group of the bound 3-phosphoglycerate
would be repelled by the phospho group on His-8, and would probably
move to form a salt bridge with Arg-59 ('c' in fig. 1.8). The 3-
phosphoglycerate at the active site would now be in a suitable
position to become phosphorylated at its carbon 2 position, in an
identical reaction to that which occurs in the glycolytic mutase
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reaction, forming 2,3-bisphosphoglycerate at the active site ('d'
in fig. 1.8). Dissociation of 2,3-bisphosphoglycerate would give
rise to the synthase activity, leaving the unphosphorylated enzyme
ready to bind another molecule of 1,3-bisphosphoglycerate.
The reaction mechanism proposed above is consistent with the
structural and kinetic data available for phosphoglycerate mutases.
Furthermore, it serves to highlight the close relationship of the
mutase and synthase activities, which only differ in the retention
or release of the 2,3-bisphosphoglycerate which is formed in each
reaction. This relationship, and a possible molecular basis for
the differing ratio of the two activities found in the B/M-type and
E-type isoenzymes, are discussed more fully in the following
section.
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1.10 The synthase/mutase relationship
As we have seen, the mutase and synthase activities of
phosphoglycerate mutase are closely related - differing only in a
tendency to retain (mutase) or release (synthase) 2,3-BPGA when it
is formed at the active site. The ancestral form of the enzyme
(corresponding to the M and B isoenzymes in vertebrates and the
yeast enzyme) is primarily a constituent of the
glycolytic/gluconeogenic enzyme pathway, and possesses a very high
mutase:synthase activity ratio; typically 10000:1 in vertebrates
such as pigs (Pons et al., 1985; Bartrons and Cameras, 1982) and
30000:1 in yeast (Sasaki et al. , 1976). This suggests that 2,3-
BPGA is very seldom released from the active sites of these
enzymes. Occasionally, hydrolysis of the phospho-enzyme will
occur, giving rise to a need for rephosphorylation. In vertebrate
tissues, 2,3-BPGA exists at suitable levels to act as a phospho-
donor (Tauler et al., 1987). In other organisms such as yeast,
which possess no separate synthase isoenzyme, the levels of 2,3-
BPGA may be extremely low. These enzymes may be re-phosphorylated
by 1,3-BPGA, which is also known to act as a phospho-donor (Laforet
et al., 1974), in which case they may be de facto 1,3-BPGA-
dependent rather than 2,3-BPGA-dependent.
Somewhere early in vertebrate evolution a gene duplication event
allowed the divergence of a new isoenzyme (E, also known as the
'synthase' enzyme) with an increased synthase activity. 1,3-BPGA
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became an important substrate, and 2,3-BPGA a product rather than a
transitory intermediate. What evidence exists about the
relationship of the B/M and E isoenzymes?
1.10.1 Kinetic constants
Table 1.2. Comparison of mutase and synthase activities
for the E isoenzyme with those of the B isoenzyme from three
species of vertebrate.
species mutase synthase reference
activity activity
human 1.4% 45x Ikura et al., 1978
chicken 0.08% 30x Bosch et al., 1982
pig 0.3% 75x Tauler & Carreras, 1987
Table 1.2 summarises the changes in mutase and synthase activities
(compared to their B isoenzymes) found for the E isoenzymes of
three species of vertebrates. On average, the E isoenzyme retains
about 0.6% of the mutase activity of the B isoenzyme, and displays
a fifty-fold increase in synthase activity. This shifts the
mutase:synthase activity ratio from 10000:1 for the B form to
about 1:1 for the E form. This dramatic change in the catalytic
emphasis of the E isoenzyme is reflected in changes in the affinity
constants for 2,3- and 1,3-BPGA. Thus the affinity for 2,3-BPGA
appears to have dropped [Km 0.5pM for the chicken B and pig M
isoenzymes (Rose and Dube, 1978; Bartrons and Carreras, 1982) to
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40pM for the human E isoenzyme (Rose, 1980)] whilst the affinity
for 1,3-BPGA has increased [Km 5pM for the rabbit M isoenyzme
(Laforet et al., 1974) compared to 0.4pM for the human E isoenzyme
(Pons and Cameras, 1986)]. This represents a change in the
affinity ratio of 2,3-BPGA: 1,3-BPGA by a factor of 100, from about
10:1 for the M isoenzyme to about 1:10 for the E isoenzyme.
1.10.2 Rates of phospho-transfer
Using a continuous flow and quench technique which allowed
measurements of reactions as fast as 20msec, Rose and Dube (1976)
investigated the rate of phosphorylation of the chicken B and horse
E isoenzymes by 1,3- and 2,3-BPGA. These experiments were designed
to determine whether or not a mechanism involving a phospho-enzyme
intermediate was plausible, but they also highlighted some
interesting distinctions between the B and E isoenzymes, as
summarised in table 1.3.
Table 1.3. Rate of phosphorylation of B and E isoenzymes by 1,3-
and 2,3-bisphosphoglycerate.
enzyme rate of phosphorylation (s- 1 )
1,3-BPGA 2,3-BPGA
horse E 13.5 2.3
chicken B 1.57 >1000
32
The phosphorylation of the B isoenzyme by 2,3-BPGA was too fast to
measure (but must have been at least as high as the kcat for the
mutase reaction, about 1100s-1), whereas phosphorylation by 1,3-
BPGA was very much slower, limiting the rate of the synthase
activity. In contrast 1,3-BPGA was found to be a better phospho-
donor than 2,3-BPGA for the horse E isoenzyme, reflecting its
increased synthase:mutase activity ratio. These changes are
consistent with the observed changes in the Km's for the two
moieties.
1.10.3 Molecular basis
What molecular events heralded the creation of an enzyme that
preferred to release 2,3-BPG rather than recycle it? What
alterations in the enzyme structure were responsible for the
altered specificities described above? The recent publication of
three mutase and three synthase (E) sequences, together with the
solution of the yeast mutase crystal structure, allow us to make
some educated guesses. The six sequences are shown aligned in
figure 1.9. Overall they share about 35% sequence identity. If
one restricts comparisons to the regions which appear to bound the
active site in the yeast enzyme (boxed), then the identity rises to
61%. The active site of the E isoenzyme has been modelled to fit
the known crystal structure of the yeast enzyme using the program
FRODO, and the two active sites are shown in figures 1.10 and 1.11.
There are only three positions in which one side-chain is conserved
in mutases and another in synthases, possibly indicating important
changes related to enzyme function. Firstly, there is position 11
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(yeast numbering) which is a serine in mutases and is thought to
provide a phospho-ligand for the transferrable phospho-group of
2,3-BPGA. In synthases, this residue is a glycine, and could thus
perform no binding function. Secondly, there is residue 21 - a
glycine in mutases and a serine in synthases. Inspection of the
yeast structure reveals that the side-chain points away from the
active site and therefore is unlikely to be involved in the binding
of substrates. Lastly, there is residue 60 - an alanine in mutases
but a serine in synthases. Intriguingly, this side-chain appears
to be in a suitable position to provide a phospho-ligand for the
non-transferrable phospho-group.
In other words, a 'shift' in phospho-ligands appears to have taken
place in the synthase (E) enzyme with respect to its progenitor.
Could this account for the observed reduction in the affinity for
2,3-BPGA and the concurrent increase in the affinity for 1,3-BPGA?
As these substitutions presumably occurred successively, would each
of the possible intermediate forms of the enzyme (ie S11/S59 and
G11/A59) possess mutase and synthase activity, and in what ratios?
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HE QAAIKK VEDQGK VK QAK K
ME QAAIKK VDDQGK VK QGK Q
RE QAAIKK VENQGK VK RAEK
Figure 1.9. Alignment of the six known amino acid sequences of
phosphoglycerate mutases. The sequences were aligned and labelled
as for figure 1.3. Residues bounding the active site in the
crystal structure of the yeast enzyme are boxed, and mutases are
separated from synthases by a horizontal line. Residues marked
with an arrow are discussed in the text.
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Figure 1.10. The active site of yeast phosphoglycerate mutase.
The polypeptide backbone is represented by the green ribbon; side
chains discussed in the text and the two sulphate groups are
labelled. This diagram was produced using FRODO.
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Figure 1.11. The modelled active site of a synthase enzyme. The
polypeptide backbone is represented by the green ribbon; side
chains discussed in the text and the two sulphate groups are
labelled. This diagram was produced using FRQDO.
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1.11 The C-terminal tail
Early in studies on the purification of yeast phosphoglycerate
mutase, it was noted that electrophoretically-separable components
of differing activity were formed (Chiba and Sugimoto, 1959).
Subsequently, five components were identified, from I - the most
active, and probably wild-type, to V the least active.
Components II to V were progressively formed from component I
during the autolysis of the yeast, and amino acid analysis of
component V showed that it had lost about 12 residues of
composition Glx, Asx, 2 Gly, 4.5 Ala, Val and 1.8 Lys when
compared to component I (Sasaki et al., 1966). Analysis of the
2,3-BPGA phosphatase activity of components I and V showed that
they possessed the same basal- level of activity. However, when the
potent phosphatase activator 2-phoshoglycollate was included, it
was found that component V was much less strongly activated than
component I (Sasaki et al., 1971b). The loss of about ten residues
of rabbit muscle M-type phosphoglycerate mutase caused by
proteolytic digestion with thermolysin resulted in the loss of all
mutase activity but did not drastically change the conformation of
the enzyme, which retained its ability to bind to cibacron blue-
Sepharose (Price et al., 1985b).
The coincident solution of the crystal structure (Winn et al. ,
1981) and amino acid sequence (Fothergill and Harkins, 1982) of
yeast phosphoglycerate mutase shed fresh light on these
observations. It became apparent that the enzyme possessed a C-
terminal 'tail' which did not crystallise, presumably due to its
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flexibility (Winn et al. , 1981). The amino acid sequence of this
C-terminal region, with its high glycine and alanine content,
supported the 'flexible tail' theory. It also gave a good match to
the amino acid composition of the residues lost from component V.
If a tail-less enzyme was inactive, then the tail must play an
essential role in catalysis; but what might that be? Model
building showed that the tail could modulate access to the active
site of the enzyme (Winn et al., 1981), and it was suggested that
the two C-terminal lysines might play some role in the active site
itself (Fothergill and Harkins, 1982), possibly by providing an
extra phospho-ligand for the transferrable phospho group. Lysine
residues are found at the C-termini of the three mutases and the
i
three synthases for which sequences are available (fig. 1.9).
The above evidence has led to the postulation of the following
three roles for the C-terminal tail (Fothergill-Gilmore and Watson,
1989) :
i) It physically excludes water from the active site.
ii) It provides a ligand or ligands to stabilise the developing
transition state, preventing phosphatase activity.
iii) It helps, by the charge stabilization of the lysine
residues, to retain the cofactor/intermediate 2,3-BPGA during the
reaction sequence.
Site-directed mutagenesis could be employed to test these ideas,
for example by altering the length or flexibility of the tail or by
changing one or both of the two C-terminal lysine residues.
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1.12 Aim of project
The aim of this project was to improve our understanding of the
molecular basis for the reactions catalysed by yeast
phosphoglycerate mutase through the design and analysis of specific
mutant forms of the enzyme. Recent rapid advances in recombinant
DNA technology, and particularly in the technique of site-directed
mutagenesis, have made such an approach feasible. The evidence
gained from previous kinetic and structural studies of the enzyme,
and detailed in the prece ding pages, suggested two areas
especially amenable to further study :
a) The importance of serine 11 to the mutase and synthase
activities of the enzyme.
b) The role played by the C-terminal lysine residue in the three
reactions catalysed by phosphoglycerate mutase.
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1.13 Strategy of project
The ab initio requirement of any project involving site-directed
mutagenesis is that the gene coding for the enzyme to be studied
has been identified. In the case of yeast phosphoglycerate mutase,
a recombinant vector isolated from a yeast chromosomal DNA library
had been shown to complement a phosphoglycerate mutase deficient
strain of yeast (Kawasaki and Fraenkel, 1982). This plasmid, which
was presumed to carry the gene for yeast phosphoglycerate mutase,
was kindly made available to us by Professor Dan Fraenkel.
The initial strategy of the project was to localise and sequence
the phosphoglycerate mutase gene. A knowledge of the DNA sequence
would allow the design of oligonucleotides which could introduce
the desired mutations in the gene. In order to study the effect of
the mutations generated, the mutant genes would be expressed in a
strain of yeast which carried no chromosomal copy of the wild-type
gene. The resultant mutant enzymes would be purified and
kinetically characterised using established techniques in order to
assess the effect of the mutations introduced.
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TGI K12, A(lac-pro), supE, thi( hsdDS/F'traD36,
proA+B+, lacl<' , lacZAMlo.
S.cerevisiae:
DBY747 leu2-3.2-112 his3A ura3-n2 trpl.
DBYgpm- leu2-3,2-112 ura.3-52 tr^t Agpm-
2.1.2 Vectors
vector source
YEP13.GPM Professor D. Fraenkel, Harvard University.
M13mpl9
M13mp9
Bethesda Research Laboratories (U.K.) Ltd.,
Cambridge, U.K.
pK19 Dr A. Boyd, Dept. of Biochemistry,
University of Edinburgh.
YIP1 Dr J. Beggs, Dept. of Molecular Biology,
University of Edinburgh.




a) Difco labs, Central Avenue, East Molesly, Surrey
Bactopeptone, purified agar, yeast nitrogen base without
amino acids.
b) Qxoid Ltd., Haverhill, Suffolk
Agar No.1, tryptone, yeast extract.
c) Sigma Chemical Company, Poole, Dorset
Ampicillin, kanamycin, tetracycline, Xgal, IPTG, all amino
acids and nucleotides.
2.1.4 Radiochemicals
Amersham pic, Lincoln Place, Aylesbury, Buckinghamshire
Deoxyadenosine 5'-( ct-32P)triphosphate, triethylammonium
salt, stabilised aqueous solution 3000Ci/mmol.
Deoxyadenosine 5'- a -(3 5 S)thiotriphosphate,
triethylammonium salt, stabilised aqueous solution
>400Ci/mmol.
Adenosine 5'-( Y -32P)triphosphate, triethylammonium salt,
stabilised aqueous solution 3000Ci/mmol.
44
2.1.5 Enzyme assays and purification
a) Boeringher Mannheim, Bell lane, Lewes, East Sussex
Enolase, pyruvate kinase, lactate dehydrogenase,
phosphoglycerate kinase, glyceraldehyde-3-phosphate
dehydrogenase, creatine phosphokinase, creatine phosphate,
2-phosphoglycerate, 3,4-dichlorisocoumarin.
b) Sigma Chemical Company, Fancy Road, Poole, Dorset
3-phosphoglycerate grades I and II,
2,3-bisphosphoglycerate, NADH, AMP, ADP, ATP,
2-phosphoglycollate, Reactive blue 2-Sepharose CL-6B,
E64c.
c) Aldrich Chemical Company Ltd., New Road, Gillingham, Dorset
1,10-phenanthroline.
2.1.6 Enzymes
a) Northumbria Biologicals Limited, South Nelson Ind. Est.,
Cramlington, Northumberland
Klenow fragment, T4 polynucleotide kinase, Alul, BamHI,
Bglll, EcoRI, HindllI, PstI, PvuII, Sail, Smal, Xhol.
b) Boeringher Mannheim





All oligonucleotides were synthesised by:
OSWEL DNA service, Dept. of Chemistry, University of
Edinburgh, West Mains Road, Edinburgh.
2.1.8 Miscellaneous
a) Amersham
Hybond-N roll, Hyperfilm MP X-ray film,
Site-directed mutagenesis kit.
b) Cambridge Bioscience, Newton House, Devonshire Road, Cambridge
Sequenase™ DNA sequencing kit.
c) Millipore (UK) Ltd.,Peterborough Road, Harrow, Middlesex
Millex-GS 0.22pm filter units.
d) Sigma
Polaroid 665 film, agarose, low melting temperature agarose
e) A & J Beveridge Ltd, 5 Bonnington Rd Lane, Edinburgh
5, 15 and 50ml Falcon tubes.
f) Pharmacia
Hexadeoxyribonucleotides.
All other biochemicals were supplied by Sigma and B.D.H., Poole,




Good laboratory practice was observed at all times. In work
involving DNA manipulation or growth of micro-organisms, sterile
technique and equipment were used. After use, plastic-ware was
incinerated, and glassware used for the- growth of bacteria or yeast
was soaked in hypochlorite bleach prior to washing. The guidelines
for the use of radioactive isotopes were strictly adhered to.
2.2.2 Standard experimental techniques
The standard experimental techniques listed below are described in
Methods in Enzymology 1988, 152 'Guide to Molecular Cloning
Techniques' on the page numbers indicated.
Technique page no.
Enzymic manipulation of DNA 91-144
Growth and storage of E.coli 145-151
Transformation of E.coli 151-154
Preparation of plasmids and phage 154-170
Preparation of yeast chromosomal DNA 493-494.
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2.2.3 Radiolabelling of DNA by random priming
DNA probes from about two hundred to several thousand base pairs in
length can be labelled to a very high specific activity by the
technique of random priming (Feinberg and Vogelstein, 1983).
Solutions:
OLB Solutions A, B and C in a ratio of 2:5:3
Store at -20°C; good for three months with
repeated freezing and thawing.







Solution B 2M Hepes buffer titrated to pH 6.6 with NaOH
Solution C Hexadeoxyribonucleotides
evenly suspended in 3mM Tris-HCl, 0.2mM EDTA
pH7.0 at 90 OD2 6 o units/pl - stored at -20° C.
BSA lOmgml-1 enzyme grade
cLATP a-32P-dATP, Amersham, 3000Ci/mmol, lOpCi/pl
Klenow fragment of DNA polymerase 1 diluted to 1.5 units/pi
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Isolation of DNA for use as probe:
The DNA fragment desired as a probe was cut using the required
restriction enzymes and separated in a low melting temperature
agarose gel. The desired band was excised from the gel using a
scalpel and placed in a pre-weighed microcentrifuge tube. SDW was
added at a ratio of 1. 5ml SDW to lg of gel. The capped tube was
placed in a boiling waterbath for 7 min and then allowed to
equilibrate at 37°C for at least 10 min before labelling. Isolated
fragments were stored at -20° C and reboiled for 3 min,
equilibriated for 10 min prior to subsequent labelling. If it was
unnecessary to isolate the probe from a gel, for instance if a
whole plasmid was to be labelled, then the DNA was added directly
to the labelling reaction below.
The labelling reaction:








The reaction was allowed to run overnight at room temperature. The
mixture was boiled for 5 min prior to hybridization.
49
2.2.4 Preparation and use of end-labelled oligonucleotide probes
Oligonucleotide probes can be used to detect a single base mismatch
and are hence invaluable in distinguishing mutant from wild-type
clones. They can also be designed from a protein sequence in order
to detect the corresponding DNA sequence.
Solutions :
lOx kinase buffer 1M Tris pH8.0
lOOmM MgClz
70mM DTT
sterilize by filtration and store at -20°C.
20xSSC 3M NaCl
0.3M trisodium citrate
Heparin 50 mg.ml- 1 in 4xSSC.
a) Preparation of labelled probe:
The following were mixed in a microcentrifuge tube:
Oligonucleotide (2.5-3 OD units/ml) 1.5pl
lOx kinase buffer 3pl
30pCi [V -32P]ATP 3000Ci/mmol 3pl
SDW 22pl
2 units of polynucleotide kinase were added and the microcentrifuge
tube was incubated in a lead pot at 37° C for 30 mins. The
oligonucleotide was present in a 1.5 fold molar excess over the
ATP, and it was not neccessary to remove unincorporated label. The




The Hybond-N filter (from Southern blot or slot-blot) was pre-
hybridized in 10ml of (6xSSC, 0.2%(w/v) SDS, 40pl heparin) at 67°C
for 1 hr in a suitable plastic box then removed and rinsed in 50ml
of 6xSSC for 1 minute. The filter was then placed in a sealed
plastic box with 10ml of 6xSSC; the labelled probe was added and
hybridized at RT for 1 hour with gentle shaking.
c) Washing:
After hybridization, the filter was removed and washed in 100ml
6xSSC at RT for 5 minutes. At this temperature binding is fairly
nonspecific. This was done three times, then the filter was
wrapped in Saran-wrap and autoradiographed at -70° C for 1-4 hours
or overnight. By increasing the washing temperature, an
oligonucleotide can be made to differentiate between a sequence of
perfect match and a sequence with one or more base mismatches. The
temperature at which this occurs (Td) can be estimated by using the
'Wallace rule':
Td (°C) = 4x(no. of G & C bases in oligonucleotide)
+ 2x(no. of A & T bases in oligonucleotide)
\
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The filter was rewashed at 5°C below the calculated melting
temperature of the oligonucleotide in 6xSSC for 5 mins, then
autoradiographed as before. If the probe was not distinguishing
mutant from wild-type sequences then the temperature of the washing
step was increased by 2°C.
2.2.5 Southern blotting
Solutions :
Denaturing buffer 1.5M NaCl
0.5M NaOH
Neutralizing buffer 1M Tris-HCl pH8.0
1.5M NaCl
20xSSC see section 2.2.4.
Procedure:
After electrophoresis was completed, the agarose gel was
transferred to a plastic tray and any unused areas of the gel were
trimmed away with a scalpel. The gel was denatured by shaking
gently in several volumes of denaturing solution for 1 hour at RT,
then the denaturing solution was poured off and the gel was
blotted dry with paper tissues, and covered with several volumes of
neutralizing solution. After shaking at RT for at least one hour
(up to 4 hrs is acceptable), the neutralizing solution was
discarded and the blotting apparatus was prepared as follows. A
sponge was placed in a plastic tray half-filled with transfer
buffer (lOxSSC). The sponge was covered with a piece of Whatman
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3MM filter paper, pre-soaked in transfer buffer, which could dip
into the buffer at either side, acting as a wick. The gel was
placed on top of the wick and any trapped air bubbles were
squeezed out. The gel was carefully surrounded with cling film to
prevent 'short-circuits' between wick and paper towels. Next, a
piece of Hybond-N cut to the exact size of the gel was placed on
top of the gel, again avoiding air bubbles. Two sheets of pre-
soaked 3MM paper were placed on top of the Hybond filter, followed
by a 5cm stack of paper towels. Finally, a glass plate was placed
on the top of the stack with a 1kg weight on top. The blot was
left at RT overnight to allow DNA transfer to occur then the
apparatus was dismantled and the filter was allowed to air dry for
1 hr and wrapped in Saran-wrap and placed DNA side down on a
transilluminator for 3-5 mins to fix the DNA. The filter was now
ready for hybridization.
2.2.6 Slot-blotting
Slot-blotting of denatured DNA samples onto Hybond-N filters was




This method of hybridization is very simple, and heparin provides a
cost-effective means of controlling background hybridization.
(Singh and Jones, 1984)
Solutions:
Formamide 100%, deionised.
Heparin see section 2.2.4.
Hybridization solution (HS)
2ml 20xSSC




2ml 10% SDS (add last)
Total volume 10ml - may need more if >1 filter is to be
probed.
Procedure:
HS was warmed to 42° C and the Hybond blot was pre-hybridised at
42°C for 10 min or longer, then placed in a sealable plastic bag.
The HS was added and the bag was heat-sealed after expelling as
much air as possible. The labelled probe was boiled (if double-
stranded) for 5 min, then a corner was cut off the bag and the
denatured probe was added to the HS. The bag was resealed and the
contents were thoroughly mixed. The bag was placed in a waterbath
at 42°C and shaken overnight. The next morning the bag was opened
and HS disposed of carefully in a designated sink. The blot was
carefully removed from the bag and washed in a plastic box at the
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required temperature and ionic strength for 15 min. When probing
for identical sequences, a stringent wash in O.lxSSC at 65°C was
required. The blot was checked for activity with a Geiger counter,
and rewashed if necessary. Finally, the blot was wrapped whilst
still moist in Saran-wrap and autoradiographed.
Re-use of filters:
If a Hybond filter was to be re-probed, hybridised probe was first
stripped off. The filter was first incubated at 45°C in 0.4M NaOH,
then transferred to O.lxSSC, 0.1% (w/v) SDS, 0.2M Tris-HCl pH7.5
and incubated for a further 15 min. It could then be stored at 4°C
in Saran-wrap until required for re-hybridisation.
2.2.8 DNA sequencing
The 'Sanger' or 'dideoxy' method of DNA sequencing was used, as
supplied in kit form (Sequenase™ DNA sequencing kit, available
from Cambridge Bioscience). The use of Sequenase™, a modified T7
DNA polymerase, allowed extended sequences of up to 500 bases to be
read from a single primer. Sequencing gels were run on a BRL SO
sequencing system then fixed, dried down on 3MM paper and
autoradiographed at RT overnight using Hyperfilm MP.
2.2.9 Site-directed mutagenesis
Several methods for oligonucleotide-directed in vitro mutagenesis
have been developed (for review, see Carter, 1986). All require a
single-stranded DNA template (usually phage M13) which carries the
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gene to be mutated and sin oligonucleotide carrying the desired
mutation which can act as a primer for DNA synthesis. All give
rise to a mixed dsDNA molecule composed of one mutant and one wild-
type DNA strand. The methods differ in the way that they enrich
for the mutant DNA sequence.
The method chosen here was that first reported by Fritz Eckstein
and his co-workers (Taylor et al., 1985) and supplied in kit form
by Amersham. The protocol is summarised in figure 2.1. Briefly,
it makes use of the finding that dCTPaS, a phosphorothioate
analogue of dCTP, can be incorporated into a growing DNA strand by
DNA polymerase but will render that strand resistant to cutting by
restriction enzymes such as Neil. Utilizing this protective
effect, the wild-type DNA strand is nicked by Neil and subsequently
removed by digestion with ExoIII, leaving the mutant strand as a
template for the synthesis of wholly-mutant dsDNA. When
transformed into E.coli, this DNA should give rise to a high
percentage of mutant plaques.
2.2.10 Growth of yeast
Yeast can be grown in rich non-selective media, or in synthetic
media which allows selection for those cells which have the ability
to synthesise a particular amino acid such as leucine or histidine.
Thus a strain such as DBY747 which is leu2- will only grow in leu-


























2 units T4 DMA ligase
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Transformation
Figure 2.1. The Eckstein method of oligonucleotide-directed
mutagenesis. The structure of the phosphorothioate analogue of
dCTP is indicated in the top right hand corner (adapted from the




(1) Amino acid stock solutions
omission stock:
g/100ml g/100ml
Adenine 0.1 Isoleucine 1.5
Uracil 0.1 Phenylalanine 0.25
Tyrosine 0.12 Valine 0.75
Lysine 0.12 Threonine 1.0
Arginine 0.1 Serine 1.75
Methionine 0.1 Glutamic acid 0.5
Aspartic acid 0.5
Leucine stock solution : 0.5% (w/v) leucine
Tryptophan stock solution: 0.2% (w/v) tryptophan
Histidine stock solution: 0.1% (w/v) histidine
Each stock solution was made up with distilled rater, sterilised by
autoclaving at 15lb/in2 for 15 min and stored at 4°C (tryptophan
stock was stored covered in aluminium foil to keep out light). To
produce the desired selective media or plates, 10ml of each of the
stock solutions required were added by sterile technique to 970ml
of YOD/YOGE media or agar prior to pouring.
(2) Media









The above media were made up to the required volume with distilled
water and sterilised, by autoclaving.
Glucose was replaced by 3% (w/v) glycerol plus 3% (w/v) ethanol in
the recip es above to produce YEPGE and YOGE media respectively.
(3) Agar
YEPD/YEPGE agar: 20g agar No.l made up to 1 litre with
YEPD/YEPGE media and sterilised by autoclaving.
YOD/YOGE agar: 20g purified agar made up to 1 litre with
YOD/YOGE media and sterilised by autoclaving.
Regeneration agar: 181.2g/l sorbitol added to the required agar
prior to autoclaving.
2.2.11 Transformation of yeast
There are two distinct methods for the transformation of yeast -
one which uses alkali cations such as lithium, and the other which
involves the enzymatic digestion of the yeast cell wall.
2.2.11.1 Spheroplast transformation
Successful transformation of yeast spheroplasts was first reported
by Beggs (1978). This method is more complex and requires more care
than the LiAc method, but is capable of generating much higher
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transformation efficiencies. The method used here is that of
Burgers and Percival (1987). The enzyme used is lyticase, which is
prepared from the gut of a snail!
Solutions:
SCEM 1M sorbitol
0.1M sodium citrate pH 5.8
lOmM EDTA
autoclave then add 30mM 2-mercaptoethanol.
STC 1M sorbitol
lOmM Tris.HCl pH 7.5
lOmM CaClz









Transformation efficiency is very dependent on careful handling of
the fragile spheroplasts. Whole cells were spun gently at 2000rpm
(500g) and spheroplasts at 1200rpm (200g) in a MSE benchtop
microcentrifuge at room temperature in order to maximize survival.
A 50ml culture of the strain to be transformed was grown up
overnight a density of about 3xl07 cells.ml-1, transferred to a
50ml Falcon tube and harvested by centrifugation at 4°C for 10 min.
The cells were washed successively in 20ml SDW and 20ml 1M sorbitol
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by resuspension followed by 5 min spins, then resuspended in 20ml
SCEM. 1000U of lyticase was added and the cells were incubated at
30°C with occasional inversions. Spheroplasting was monitored by
measuring the decrease in absorbanee at 800nm of a ten-fold
dilution of cells in water. Spheroplasts lyse under these
conditions, giving rise to a decrease in absorbance at 800nm. When
over 90% were spheroplasts (15-20 min), cells were harvested for 3-
4 min and the pellet was washed successively in 20ml 1M sorbitol
and 20ml STC by gentle resuspension followed by 3-4 min spins.
Finally, the pellet was resuspended in 2ml STC. Aliquots of 0.1ml
were taken and mixed with plasmid DNA plus carrier (sonicated
herring sperm) DNA to a total of lOpg in a 15ml Falcon tube and
left at RT for 10 min. 1ml PEG was added and the tubes were
inverted several times to mix, then incubated at RT for a further
10 min prior to harvesting for 4 min. The pellets were
resuspended in 150pl SOS and incubated at 30° C for 20-30 min or
overnight. To plate out, 8ml molten regeneration agar kept at 45-
46° C was added mixed by inversion and poured onto warm selective
plates. Once the agar had solidified, the plates were inverted and
incubated at 30°C. Colonies appeared in 3-7 days.
2.2.11.2 Lithium acetate transformation
Transformation of intact yeast cells treated with alkali cations
was reported by Ito et al., (1983). This method of transformation
is quick and simple, but may not give a high enough transformation
efficiency for some purposes.
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Solutions:
LA 0.1M lithium acetate in TE (lOmM Tris-HCl pH8.0, lmM
EDTA)
PEG 50% PEG 4000
filter sterilized
SOS Non-selective media with appropriate amino-acid
supplements
Procedure:
A 50ml culture of the recipient strain was grown to a density of
approx. lxlO7 ml-1, harvested with a 5 min spin (500,g, 2000rpm in
an MSE benchtop centrifuge) and resuspended in 10ml TE, then spun
down again and resuspended in 5ml LA buffer. The cells were shaken
for 1 hr at 30° C, then dispensed into 0.3ml aliquots in
microcentrifuge tubes. Plasmid DNA, plus carrier DNA to a total of
lOpg, was added, followed by 0.7ml PEG. Tubes were inverted
several times to mix and placed in a 30°C waterbath for 1 hour,
then heatshocked for 5 min at 42°C. The cells were then
centrifuged for 10s at low speed in a microcentrifuge, the
supernatant discarded and the cells resuspended in 0.3ml SOS.
Samples were incubated at 30°C for 20-30 min or overnight, then
spread on to warm selective plates. Once dry, plates were
inverted and incubated at 30°C. Colonies appeared in 2-4 days.
2.2.11.3 Analysis of yeast transformants
Yeast colonies obtained from selective plates must be analysed to
ensure they carry the correct plasmid and are not due to
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contamination. The most convenient way to do this is to rescue the
plasmid from yeast and use it to retransform E.coli. Plasmid
isolation from E.coli and restriction mapping can then be used to
confirm the identity of the plasmid.
Procedure:
A 5ml culture of cells was grown in selective media overnight,
transferred into microcentrifuge tubes and harvested by
centrifugation at low speed in a microfuge then resuspended in
0,4ml SCEM. 50 units of lyticase were added and the cells were
incubated at 30° C for 20 mins, checking for spheroplasts under the
microscope (mixing 5pl cells with 5pl 10% SDS and looking for >90%
cell lysis). Spheroplasts were spun down for 10s in a microfuge at
low speed and gently resuspended in 0.45ml of TE. 50pl 10% SDS
was added and mixed with a micropipette tip, then the tubes were
incubated at 65°C for 30 min. 80pl 5M KAc was added, mixed, and
left on ice for at least one hour, then the tubes were centrifuged
for 15 min in a microfuge at high speed. The supernatant was
transferred into a fresh tube (the pellet contained cell debris and
was discarded) . The DNA was precipitated by adding 1ml cold
ethanol, mixing, then centrifuging for 5 min. The pellet was
rinsed with 1ml cold 80% ethanol and air dried at 42°C, then
resuspended in 0.5ml TE. 5ul RNase (lOmg/ml) was added, mixed, and
incubated at 37°C for 20 min. An equal volume of cold isopropanol
was then added, mixed gently then centrifuged at high speed in a
microfuge for 5 min. The pellet was rinsed and air dried as
before, then resuspended in 20pl TE. Plasmids could sometimes be
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visualised directly by running in an agarose gel, however it was
usually necessary to transform E.coli with the DNA and undertake
restriction analysis from bacterial minipreps.
2.2.12 Purification of yeast phosphoglycerate mutase
This method is suitable for the purification of 0.3-5mg of
phosphoglycerate mutase from a yeast strain in which it is over-
expressed.
2.2.12.1 Cell lysis and ammonium sulphate cut:
A 0.5-2 litre culture of yeast, from which phosphoglycerate mutase
was to be purified, was grown to early stationary phase,
transferred into 250ml centrifuge bottles and centrifuged at
6000rpm (5500g) , 5 min, 4°C (JA14 rotor in J2-21 centrifuge). The
supernatant was poured off, leaving a large cell pellet which was
resuspended in 2-3 ml ice-cold lOmM Tris-HCl pH 7.5. The slurry
was transferred into a small glass beaker (50-100ml) and the volume
estimated. Protease inhibitors were added (see section 2.2.12.5),
followed by glass beads (0.4mm diam.) until no surface liquid was
visible. The beaker was placed in an ice-bucket and the cells
were homogenised with a motorised teflon pestle at 1200rpm for
1.5-2 min (when slurry became more fluid and possibly frothy). 10-
15ml cold lOmM Tris-HCl pH 7.0 was added and the beads were stirred
with a glass rod to wash out protein, pouring the supernatant into
a 100ml measuring cylinder. This step was repeated 4-5 times
until the supernatant became almost clear. After estimation of the
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volume it was transferred into a 250ml conical flask and enough
solid ammonium sulphate to make a 55% saturated solution was added.
The flask was stirred slowly on ice for 10-15 min to dissolve the
salt, then heated in a water bath to 70°C for 5 min, stirring
occasionally, to denature proteins, cooling to 4°C on ice
afterwards. The liquid was then immediately transferred into SS34
centrifuge tubes and spun at 12000rpm (17400g"), 25 min, 4°C (JA20
rotor in J2-21 centrifuge). After this step much of the protein
and cell debris had precipitated, leaving most of the mutase in
solution. The supernatant was decanted, its volume estimated and
solid ammonium sulphate was added to make the solution 70%
saturated. It was then stirred slowly on ice for at least 30 min
(or kept overnight in the fridge). The solution was transferred
into SS34 tubes and spyn as before to precipitate the enzyme. The
supernatant was discarded and the pellet resuspended in a small
volume of 80% saturated ammonium sulphate (l-2ml) and transferred
into a microcentrifuge tube. The enzyme is stable indefinitely in
these conditions at 4°C.
2.2.12.2 Affinity chromatography:
As previously discussed, cofactor-dependent phosphoglycerate
mutases from all sources studied share the ability to bind to
cibacron-blue Sepharose. This property is shared by many
glycolytic enzymes, probably refecting their common structural
motif of a-helix and 0-sheet (Price and Stevens, 1983).
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Phosphoglycerate mutase can be purified by allowing binding to
cibacron blue-Sepharose and then specifcally eluting the enzyme
with substrate or cofactor.
Procedure:
This procedure is based on that reported by Price and Stevens
(1983) but uses 3-PGA for the specific elution of phosphoglycerate
mutase rather than 2,3-BPGA, which was found to be less specific.
The sample obtained in section 2.2.12.1 was centrifuged at high
speed for 10 min in a microcentrifuge. The pellet was re-dissolved
in 500ql lOmM Tris-HCl pH7.5 ('Tris') and dialysed overnight
against 21 Tris at 4°C to remove the ammonium sulphate. A
cibacron-blue Sepharose column (10cm by 1cm internal diameter) was
equilibrated with Tris. The dialysed sample, about 1ml in volume,
was added to the top of the column. The column was washed with
Tris, pumped at one column volume per hour, until all the unbound
material had been eluted. A UV monitor was used to detect protein
in the eluent at 280nm. Next, two column volumes of Tris plus ImM
NADH, ImM AMP were passed through the column to elute
dehydrogenases and kinases, followed by two column volumes of Tris.
Phosphoglycerate mutase was eluted by washing with two column
volumes of Tris plus lOmM 3-PGA (Sigma grade II sodium salt). The
enzyme normally eluted in a volume of 4-5ml. Finally, the column
was washed with 2 column volumes of Tris plus 5M NaCl to elute all
remaining bound proteins and to regenerate the column. A typical
trace of absorbance at 280nm of eluted material is shown in figure
2.2. The eluted phosphoglycerate mutase was assayed for protein
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sample on 1mM NADH/AMP
time
t t
10mM 3-PGA 5M NaCI
Figure 2.2. Schematic representation of a typical trace of
absorbanee at 280nm of the eluent from the cibacron blue-Sepharose
column during' the purification of phosphoglycerate mutase.
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concentration and activity as described (2.2.12.3 and 2.2.12.4),
then was made 80% ammonium sulphate saturated and stored at 4° C
until required.
2.2.12.3 Determination of protein concentration
During purification of phosphoglycerate mutase, protein
concentration was estimated by the method of Layne (1957) . The
absorbance of a suitably diluted sample of protein in a quartz
cuvette was read at 280nm and 260nm against a water blank. The
concentration of protein in mg/ml is given by the equation:
1.55x(A2so) - 0.76x(Aa6o)
For pure samples of phosphoglycerate mutase, the extinction
coefficient of the enzyme at 280nm was used to calculate the
concentration of the enzyme. For yeast phosphoglycerate mutase,
A2 s 0 1.45 = lmg.ml- 1 protein.
2.2.12.4 Assay of phosphoglycerate mutase activity
During purification, the total phosphoglycerate mutase activity of










A sample of phosphoglycerate muta.se was added to the assay mix in a
quartz cuvette, mixed, and the rate of increase in absorbance at
240nm due to the formation of PEP was monitored in a recording
spectrophotometer. One Enzyme Unit (1 EU) is defined as giving a
rate of increase in absorbance at 240nm of 0.1/min. The
phosphoglycerate mutase sample was first diluted so that <0.15 EU's
were added to the assay. Pure yeast phosphoglycerate mutase has a
specific activity of 7000-8000 EU's/mg (Price and Jaenicke, 1982).
2.2.12.5 Protease inhibitors:
The following protease inhibitors were added to cell slurries prior
to breakage to prevent degradation of the enzyme
i) 3,4-Dichlorisocoumarin - inhibits serine proteases
stock solution - 5mM in DMSO, diluted x50 for use.
ii) 1,10-Phenathroline - inhibits metalloenzymes
stock solution - lOOmM in DMSO, diluted xlOOO for use.
iii) E64c - inhibits cysteine proteases
stock solution - ImM in SDW, diluted x50 for use.
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2.2.12.6 Denaturing gel electrophoresis
Polyacrylamide gel electrophoresis was carried out according to the
method of Laemmli and Favre (1973). Protein samples were prepared
by mixing with an equal quantity of boiling mix (10% (v/v) stacking
gel buffer, 2% (w/v) SDS, 5% (v/v) 2-mercaptoethanol, 10% (v/v)
glycerol and 0.005% (w/v) bromophenol blue), boiling for 3 min and
centrifuging for 10s at high speed in a microfuge prior to loading.
2.2.13 Estimation of the kinetic parameters of wild-type and mutant
phosphoglycerate mutases
2.2.13.1 Michaelis constants for 3-PGA and 2,3-BPGA
The Km's of wild-type and mutant phosphoglycerate mutases for the
glycolytic substrate 3-phosphoglycerate and the cofactor 2,3-
bisphosphoglycerate were estimated in an assay coupled through
enolase, pyruvate kinase (PK) and lactate dehydrogenase (LDH) to

















The assay was started by the addition of a sample of
phosphoglycerate mutase, diluted so as to give a maximum velocity
not exceeding 2 nmoles NADH oxidised per minute. Under these
conditions, the rate of reaction was determined solely by the
activity of phosphoglycerate mutase. In experiments to determine
the Km for 3-PGA, 2,3-BPGA was present at constant non-rate-
limiting concentrations, and vice-versa. The reaction was
monitored by the decrease in absorbance at 340nm, due to the
oxidation of NADH, for 4 min in a Phillips PU 8720 UV/VIS scanning
spectrophotometer at 30°C. Plastic UV cuvettes were used, and four
cuvettes were monitored simultaneously. All measurements were
carried out in triplicate, and standard deviations were calculated.
Rates were converted to umoles NADH oxidised/min/umoles of subunits
of phosphoglycerate mutase using the absorbance coefficient for
NADH at 340nm of 6.2 pM"'. crK1.
2.2.13.2 Estimation of the Michaelis constant for 2-PGA
The Km's of wild-type and mutant phosphoglycerate mutases for the
gluconeogenic substrate 2-phosphoglycerate were determined using an
assay coupled through phosphoglycerate kinase (PGK) and














The assay was carried out as described in section 2.2.13.1.
2.2.13.3 Synthase activity of phosphoglycerate mutase
A low 2,3-BPGA synthase activity has been identified in vertebrate
phosphoglycerate mutases, and in one instance in yeast
phosphoglycerate mutase (Sasaki et al. , 1976). In order to detect
any synthase activity in the wild-type and mutant forms of the
yeast enzyme, the assay of Laforet et al., (1974) was used. This
assay overcomes the problems caused by the inherent instability of
1,3-BPGA by continually synthesising this substrate from ATP and 3-
PGA using the enzyme PGK. This reaction is driven by the
continuous regeneration of ATP from ADP and creatine phosphate by
the enzyme creatine phosphokinase (CPK). The addition of a sample
of phosphoglycerate mutase leads to a complicated situation
involving the interconversion of 1,3-BPGA, 2,3-BPGA, 3-PGA and 2-
PGA. The synthesis of 2,3-BPGA should be favoured by the continual



















The reaction mix was equilibrated in a microcentrifuge tube at 30°C
for 5 min. A sample of phosphoglycerate mutase was added and
mixed, and the assay was incubated at 30°C for 30 min, then boiled
for 10 min (this hydrolyses any 1,3-BPGA, and largely inactivates
the enzymes, although phosphoglycerate mutase is fairly heat
resistant). 62pl cold 25% TCA was added and the tubes were
vortexed and kept on ice for 30 min to ensure complete denaturation
of the enzymes, then centrifuged at high speed for 10 min in a
microcentrifuge. 150ul of the supernatant was removed and
neutralised by the addition of 25pl 1.8M Tris-HCl pH8.0 and 8yil 3M
NaOH to give a final pH of about 7.5. Control samples, in which
the reaction was stopped at time zero by the addition of TCA, were
also processed and served as blanks for the correction of any non¬
specific effects.
The amount of 2,3-BPGA produced in the above reaction was
determined by monitoring its ability to activate phosphoglycerate
mutase. Phosphoglycerate mutase activity was monitored using the
enolase-coupled assay system (section 2.2.10.4) containing 5mM 3-
PGA and no 2,3-BPGA. A standard curve was produced by adding known
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concentrations of 2,3-BPGA to the assay system and monitoring the
activity of 1 EU of phosphoglycerate mutase. This was found to be
linear in the range 0-7 nmoles 2,3-BPGA, and is presented
graphically in figure 2.3. The low activity observed in the
absence of added 2,3-BPGA was probably due to a low level of
contamination of Sigma grade I 3-PGA by 2,3-BPGA. Using this
assay, 25pl aliquots from the neutralised, stopped synthase assay
were used to determine the amount of 2,3-BPGA produced by each
sample of enzyme studied.
2.2.13.4 Phosphatase assay
The 2,3-BPGA phosphatase activity of phosphoglycerate mutase
samples in the presence and absence of the activator 2-
phosphoglycollate was measured using the following assay system:










The reaction mix was equilibriated in a microcentrifuge tube for 5
min at 30° C, then a sample of the phosphoglycerate mutase to be
studied (2-20qg) was added and the reaction was allowed to proceed
for 1 hr at 30° C. 200pl cold 25% TCA was added to stop the
reaction and the tubes were kept on ice for 10 min, then
centrifuged at high speed for 10 min at 4°C. Control samples, in
74
2,3-BPGA (nmoles)
Figure 2.3. Standard curve obtained for the determination of the
amount of 2,3-bisphosphoglycerate formed in the synthase assay.
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which the reaction was stopped at time zero by the addition of TCA,
were used as blanks in order to correct for any interfering
effects.
b) Determination of Pi:
The amount of inorganic phosphate released in the phosphatase
reaction was measured using the assay of LeBel et al., (1978).
Solutions:
A: 0.25% copper sulphate pentahydrate
4.6% sodium acetate trihydrate
in 2N acetic acid.
B: 5% ammonium molybdate
C: 2% Elon (p-methyl-aminophenol sulphate)
5% sodium sulphite
Procedure:
0. 5ml of the TCA supernatant of the sample was placed in a 5ml
Falcon tube. 1.5ml of solution A and 250pl of solution B were
added and mixed thoroughly, then 250pl of solution C was added
followed by further mixing. The tubes were allowed to stand for at
least 7 min to allow colour to develop, and absorbance was then
read at 870nm. A standard curve for Pi was constructed using
acidified KH2PO4 of known concentrations in triplicate. Mean
values together with SD's are plotted in figure 2.4. The standard
curve was found to be linear in the range 0-7pg Pi.
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Figure 2.4. Standard curve obtained for the quantitation of
inorganic phosphate released in the phosphatase assay.
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2.2.14 Computer programs
a) Sequence analysis and manipulation:
The University of Wisconsin Genetics Computer Group (UWGCG) suite
of programs were used for the analysis and manipulation of DNA and
protein sequences (Devereux et al., 1984).
b) Protein structure modelling and display:
FRODO, written by Alwyn Jones and converted to run on a VAX under
VMS on the Evans and Sutherland PS300, was used for the display and
modelling of protein structures.
c) Statistical analysis and presentation of data:
The program DNRP53 (Duggleby, 1984) was used for non-linear
regression analysis of data. CRICKETGRAPH, run on an Apple
Macintosh microcomputer, was used for the graphical presentation of
data.
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Localisation and. Sequencing of the GPM gene.
This chapter describes the localisation of the GPM gene on the
plasmid YEP13.GFM supplied by Professor Dan Fraenkel and the
subsequent sequencing of the gene.
3.1 Restriction mapping and location of the yeast GPM gene locus
The plasmid shown by Fraenkel (Kawasaki and Fraenkel, 1982) as
capable of complementing a gpm- strain of yeast consisted of the
shuttle vector YEP13 with a 6kb insert of yeast chromosomal DNA in
the unique BamHI site. Before sequencing, the GPM gene locus had
to be located and mapped by restriction analysis. A large-scale
preparation of the plasmid was carried out and 500ng aliquots were
digested using the restriction enzymes BamHI, Bglll, EcoRI,
Hindlll, Sail and Xhol singly and in pairs. Once digestion was
complete, the restriction fragments were separated on a large
agarose gel (1%, containing EtBr). Several digests of lambda DNA
were also run to act as markers. The gel was inspected on a UV
trans illuminator, and when good separation of the fragments was
observed the DNA was transferred on to a Hybond-N filter by
Southern blotting. This filter was first hybridised with a mixture
of YEP13.GPM and lambda DNA labelled with a -3 2 P-dATP by random
priming, washed in stringent conditions (O.lxSSC, 65°C) and
autoradiographed overnight at -70°C. These probes hybridised with
every DNA fragment on the filter (fig. 3.1a), and by comparison
with the Rf values of the lambda DNA fragments each YEP13.GPM
fragment was assigned an approximate size in base-pairs. Using the
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Figure 3.1a. Restriction mapping of YEP13.GPM. Autoradiograph of a
Southern blot of YEP13.GPM cut with the following restriction
enzymes:
1. EcoRI 4. BamHI 7. Sail + Hindlll 11. Xhol + Bglll
2. HindiII 5. Bglll 8. BamHI + Sail 12. Xhol + BamHI
3. Sail 6. Xhol 9. BamHI + Hindlll 13. EcoRI + Sail
10. BamHI + Bglll 14. EcoRI + Hindlll.
Lanes a,b,c contain lambda DNA cut with Hindlll, Hindlll + EcoRI,
and EcoRI, respectively. YEP13.GPM and lambda DNA were used as
probes.
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Figure 3.1b. Localisation of the GPM coding sequence in YEP13.GFM.
The Southern blot from figure 3.1a was probed with oligonucleotides
derived from the amino acid sequence of the yeast phosphoglycerate
mutase enzyme. The oligonucleotides hybridised to one major
fragment in each lane. Some non-specific background hybridization
is also observed.
H Ba X S H B s





B - Bglll ; Ba - BamHI ; E - EcoRI ; H - Hindlll ; S - Sail ; X - Xhol
Figure 3.1c. Restriction map of the yeast chromosomal insert of
VA.
YEP13 .GPM. The location of the GPM gene, as determined by Southern
blotting experiments, is indicated.
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information obtained from the single and double digests, in
association with the known restriction map of YEP13, a map of the
yeast DNA insert was constructed (fig. 3.1c).
From our knowledge of the protein sequence it was apparent that the
GPM gene would be less than lkb in length (assuming no introns,
which are very rare in S.cerevisiae). Accordingly, the next step
was to narrow down the locus of the GPM gene in the insert. The
filter was stripped of hybridized probe and reprobed using sin
oligonucleotide designed from the N-terminus of the protein (this
was originally synthesised in an attempt to isolate the gene). The
oligonucleotide was first end-labelled with T-3 2 P-ATP then
hybridised with the Hybond filter in 6xSSC for 30 min. The filter
was then washed in 6xSSC at 45° C and autoradiographed overnight at
-70°C. The oligonucleotide hybridised most strongly to one band in
each of the YEP13.GPM digests (figure 3.1b). Referral to the
restriction map showed that all these bands contained a 1.3kb
fragment bounded by a Hindlll and a Sail site. This experiment was
repeated using an oligonucleotide designed from the C-terminus of
the protein, with the same result. These observations indicated
strongly that the GPM gene resided on a 1.3kbp Hindlll/Sall
fragment in the insert (figure 3.1c).
3.2 Subcloning and sequencing of the GPM gene
The location of the GPM gene on a 1.3kbp Hindlll-Sall fragment
allowed DNA sequencing to be used. The 1.3kbp fragment was thus




Figure 3.2. Restriction map of YEP13.GPM and sequencing strategy of
the GPM gene. The thick lines indicate the GPM coding sequence.
Arrows show the direction and length of individual sequence
determinations. Oligonucleotides used as sequencing primers are
indicated. Restriction enzymes: H - Hindlll; S - Sail; E - EcoRI;
B - Bg'lIT; Ba - BamHI; X - Xhol; A - Alul.
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gene. Subcloning into M13mpl8, which contains the polylinker in
the opposite orientation, was also attempted; but in this
orientation the insert appeared deleterious to the phage as yields
of ssDNA were always very poor. The subcloning and sequencing
strategy is summarised in figure 3.2. The Sequenase™ DNA
sequencing kit was used to allow extended readthrough from each
primer. Initially the universal primer, which hybridises near the
Sail site of M13mpl9, was used as a sequencing primer. This
allowed the location of the 3' end of the GPM coding sequence,
which terminated about 150bp upstream of the Sail site, to be
identified. The translated amino acid sequence of this 'tail'
region differed significantly from the previously reported protein
sequence (Fothergill and Harkins, 1982), (discussed later). The
fidelity of the DNA sequence was confirmed by the isolation of an
Alul restriction fragment in M13mp9 which allowed sequencing of the
complementary DNA strand for this region. This sequence matched
that from the other strand, vindicating the DNA-derived sequence.
In order to extend the sequencing of the GPM gene, the
oligonucleotide 181A was designed to act as a sequencing primer.
This oligonucleotide hybridised 150 bases in from the Sail site in
MWl and allowed another 350 bases of coding sequence to be read. A
further sequencing primer, oligonucleotide 342A, enabled the final
350 bases of coding sequence to be read. Finally, an
oligonucleotide synthesised by Celltech ('celltech'
oligonucleotide), and designed as a probe for the isolation of the
GPM gene from a lambda library was found to hybridise to MWl at
around codon 13 of the GPM coding sequence. This primer allowed
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823 TTTATTATTTCAAATTAAaTAGCTATATATAaTCAA8ATAAC8TTT8TTT8ACAC8ATTA 884
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Figure 3.3. Nucleotide sequence and derived amino acid sequence of
of 1154bp were sequenced, comprising a 741bp open reading frame
encoding the enzyme phosphoglycerate mutase plusthe GPM gene. The
underlined sequences are discussed in the text. Residues different
in the published protein sequence are indicated below the deduced
amino acid sequence. The DNA sequence has been lodged with the
EMBL sequence database, accesion number X06408.
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of 1154bp were sequenced, comprising a 741bp open reading frame
encoding the enzyme phosphoglycerate mutase plus some 5' and 3'
flanking sequences (figure 3.3).
3.3 Features of the DNA sequence
Phosphoglycerate mutase is typical of glycolytic enzymes in yeast
in being highly expressed. This has a number of consequences for
the DNA sequence. Most striking is the extreme codon bias
exhibited by the GFM gene. Only 31 codons are used, and of these
24 account for 93% of the amino acids. This compares with values
of 94% for phosphoglycerate kinase, 95% for enolase I and 95% for
alcohol dehydrogenase I (Bennetzen and Hall, 1982). Figure 3.4
shows the three reading frames of the GPM gene scanned for codon
bias using the UWGCG program CODONPREFERENCE. This program
compares the test sequence against a table of the codons used in
seven highly expressed yeast genes coding for other glycolytic
enzymes. The results are striking, with a high degree of bias
coinciding with a 741bp open reading frame (boxed) in the second
reading frame. Rare codons (used <10% of the time) are indicated
by a dash. Other features of the GPM sequence are also typical of
highly expressed genes in yeast. These include A residues at
positions -1 and -3 and a 44 base A-rich region containing no G
residues immediately adjacent to the initiating ATG codon (Hamilton
et al., 1987). A CT-rich block, here present at -83 to -109, is
also common in highly expressed genes, although the CAAG sequence























































Figure 3.4. Codon bias exhibited by the GPM gene. The three
reading frames of the GPM gene were scanned for degree of codon
bias, using seven highly expressed yeast glycolytic genes for
comparison. Boxes indicate open reading frames, and the ORF of the
GPM gene is present in the centre panel. Codons used less than 10%
of the time are marked with dashes.
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Transcription may initiate at the TATA box at position -138, and
the sequence CACACA at position -16 has been found in several other
yeast genes, although its function is unclear as yet (Dobson et
al. , 1982). The 3' flanking sequence is 73% AT rich, and contains
two possible transcription termination signals TAG...TAGT... TIT
starting at positions 812 and 844 (Zaret and Sherman, 1982).
3.4 Features of the protein sequence
The protein sequence deduced from the DNA sequence largely confirms
that previously determined by Edman degradation of proteolytic
c
fragments. There are several disr^epancies, as indicated in figure
3.4, and the reasons for these have been discussed by White and
Fothergill-Gilmore (1988). Briefly, they reflect both strain
differences and problems inherent in manual protein sequencing.
However, none of these discrepencies significantly alter our ideas
about the structure/function relationship of the enzyme - although
the C-terminal tail appears to be longer and more flexible than was
previously envisaged.
In summary, the gene encoding the enzyme phosphoglycerate mutase
from yeast has been identified, mapped and sequenced using standard
techniques. The gene exhibits a high degree of codon bias, and
several possible transcription/translation control elements have
been identified. The DNA-derived protein sequence largely confirms
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4.Replacement of the GFM gene
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4.1 Why gene replacement?
The purpose of this project was to design, express and
characterise mutant forms of the enzyme phosphoglycerate mutase.
These mutant enzymes were to be expressed from plasmids in yeast,
which normally possesses a single wild-type chromosomal copy of the
GPM gene, and therefore expresses wild-type phosphoglycerate
mutase. Obviously it was undesirable to have two forms of the
enzyme being expressed in the same cell because the altered
properties of the mutant form could be blurred or masked by the
presence of the cell's own wild-type mutase. Accordingly, it was
decided to create a yeast strain devoid of any wild-type mutase as
a vehicle for the expression of engineered mutases.
Two possibilities existed; to disrupt the GPM gene or to remove it
entirely. S.cerevisiae has an efficient DNA double-strand-break
repair system which can be utilised to promote homologous
recombination between the yeast genome and incoming linear DNA
fragments. DNA constructs can be designed in vitro which will
result in the disruption or replacement of target genomic sequences
when introduced into yeast cells. Generally a marker gene such as
LEU2 or HIS3 is integrated into the genome, allowing positive
selection for the integration event by plating out cells on the
appropriate omission medium. The marker gene can either disrupt or
replace the target genomic sequence. The two options are of equal
experimental complexity (indeed the methodologies are identical)
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and would each give rise to a strain of yeast with identical
phenotype. There was however one important consideration which
made gene replacement the better option in this case.
When a gene is disrupted, it ceases to express a functional
protein, but all the genetic information is still present in the
cell. If a mutant GPM gene on a plasmid were introduced into a
GPM-disrupted strain of yeast, then there would be a remote chance
that homologous recombination would occur, reconstituting the wild-
type GPM gene on the plasmid. Although rare, this event might
confer a selective advantage to the cells, such as increased
ability to utilise glucose, which would allow them to outgrow their
mutant siblings. In this way any retro-conversion could quickly
establish itself in a population of growing yeast. Undetected,
this would jeopardise the characterisation of mutants; periodic
checking would be tedious. Gene replacement, on the other hand,
removes all the coding sequence, eliminating the possibility of
reconstitution of the wild-type gene.
4.2 Strategy for gene replacement
The yeast strain DBY747 (GPM+ his3-) was chosen as the parental
strain for gene replacement. In order to replace the GPM gene, it
was necessary to construct a plasmid which carried the HIS3 gene
flanked by DNA sequences which flank the GPM gene on the yeast
chromosome. When this plasmid was linearised and introduced into
yeast, the flanking sequences on the plasmid and the chromosome
could undergo homologous recombination (figure 4.1). A number of
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Figure 4.1. Schematic outline of the process of replacement of the
GPM gene with the HIS3 gene in the yeast strain DBY747.
94
cells would gain a chromosomal copy of the HIS3 gene, with the
concommitant loss of their GFM gene. These cells could be selected
for by plating the transformants onto his- selective plates.
The plasmid construction is summarised in figure 4.2, and consisted
of two main steps. Firstly, the BamHI / Sail fragment of YEP13.GPM
was cloned into pUC18, followed by the Sail fragment which carries
the GFM gene. This resulted in the reconstruction of the GFM locus
in plasmid pUC-GFM. Secondly, the GFM gene was removed from pUC-
GPM by digestion with Xhol / Bglll, and the HIS3 gene (from the
plasmid YIP1) on a Xhol / BamHI fragment was ligated in its place,
creating the plasmid pUC-HIS3. This construct was then linearised
by cutting with the enzymes BamHI and Sail and the restriction mix
containing 3pg DNA was transformed into the yeast strain DBY747 by
LiAc transformation. The transformation mix was plated out on YOGE
his- plates to select for transformants (gpm- cells lose the
ability to grow on glucose, and must be grown with glycerol and
ethanol as carbon sources). After 7 days at 30°C 25 transformants
were obtained. The phenotype of these transformants was gpm- HIS3+
as expected. They grew happily on YGE plates but not at all on YD
plates. The expected genomic maps of the parental and derived
strains are shown in figure 4.3.
To ascertain whether or not gene replacement had occurred, a
Southern blot was prepared in the following manner. Genomic DNA
was prepared from DBY747 and from one of the transformants,
provisionally designated DBYgpm-. lOpg of DNA from each strain was





Figure 4.2. Plasmid construction required for gene replacement.
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Figure 4.3. Genomic map of DBY747 and predicted genomic map of the
strain DBYgpm- derived from gene replacement. The positions of the
GPM and HIS3 genes are indicated.
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These digests were then separated by electrophoresis on a large 1%
agarose gel, along with DNA fragments containing the GPM and HIS3
genes as markers. The DNA was transferred onto Hybond-N by
Southern blotting, and was hybridised first with the 1.3kbp
Hindlll/Sall fragment of YEP13.GPM, which contains the GPM gene,
labelled by random priming with a-32P-dATP. After hybridisation,
the filter was washed under stringent conditions (O.lxSSC, 65°C, 15
min) and autoradiographed overnight. It was then stripped of all
hybridised probe and the process above was repeated using a DNA
fragment from YIP1 containing the HIS3 gene as probe. The results
of this experiment are shown in figure 4.4. As expected the GFM
probe hybridised with a 1.3kb band in the DBY747 track, but no band
in the DBYgpm- track. Conversely the HIS3 probe detected no like
sequences in the DBY747 track, but hybridised with three bands in
the DBYgpm- track. The genomic map predicted for DBYgpm- indicates
that a Hindlll/Sall digest should generate two fragments of 4.3 and
4.2kbp containing HIS3 sequences. This doublet is present on the
autoradiograph, although the bands have merged. The two spurious
lands present are not predicted by the genomic map, but may be due
to incomplete digestion of the DNA, 'star activity' of one of the
enzymes or contaminating sequences in the HIS3 probe. Nevertheless
it is clear that the gene replacement has been successful.
In summary, the creation of a gpm- strain of yeast was a
prerequisite for the expression and analysis of mutant forms of
phosphoglycerate mutase. This was acheived by gene replacement,
and the derived strain DBYgpm- was shown to conform to the expected
genotype and phenotype.
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Figure 4.4. Southern blot analysis of gene replacement.
1. HIS3 marker
2. DBY747 genomic DNA cut with Hindlll and Sail
3. DBYgpm- genomic DNA cut with Hindlll and Sail
4. GPM marker.
Experimental details are described in the text.
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Design, Construction and Expression of mutant GPM'
100
Once a GPM deleted strain of yeast had been created, the next step
was to produce mutant forms of phosphoglycerate mutase for
analysis. Two mutations likely to prove informative were chosen.
One was the replacement of serine 11 with a glycine (S11G), which
would probe the molecular basis of the observed catalytic
differences between mutases and synthases. As discussed in the
introduction (section 1.10), residue 11 is a serine in all mutases
so far sequenced and is likely to be involved in the binding of the
substrates and cofactor. In synthases however, this residue is
always a glycine, and could perform no role in bonding. Would the
S11G mutation make yeast phosphoglycerate mutase less of a mutase
and more of a synthase? Secondly, it was decided to investigate
the role of the C-terminal 'tail' by changing lysine 246 to a
glycine (K246G). This would abolish one of the positive charges on
the tail which have been suggested as important for substrate and
cofactor binding (section 1.11). What effect would the loss of
this charged group have on the three activities of the enzyme?
This section describes the design, creation and expression of the
two mutants.
5.1 Design and construction of the mutants
In order to effect the mutations discussed, the Eckstein method
of site-directed mutagenesis was employed. This method, supplied
in kit form by Amersham, is highly efficient and is carried out in
vitro, thus abolishing the risk of incorporating spurious mutations
during DNA replication in repair-deficient cell lines. Firstly,
two oligonucleotides were designed to act as mutagenic primers.
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Each was an 18-mer and contained the 3-base substitution necessary
to produce the required mutation whilst preserving the strong codon
bias. The two oligonucleotidess are shown below, with the
differences in the wild-type sequence highlighted:
w-t gga
S11G 5'- IT CCA TTC ACC TTG ACC G - 3'
w-t nr
K246G 5'- CA GAC TTA ACC CTT ACC T - 3'
The two mutants were produced in parallel; in each case the M13mpl9
clone MW1, which contained the entire GPM gene on a 1. 3kbp
Hindlll/Sall insert, was used as a template for mutagenesis. The
double-stranded phage DNA obtained from the in vitro mutagenesis
was transformed into competent TGI cells; transformants were plated
out in top agar on a lawn of TGI cells and the plates were
incubated at 37°C overnight to allow plaques to form.
5.2 Screening for the mutants
The plaques obtained from the mutagenesis experiments could be one
of two things - mutant or wild-type. If the mutagenesis had worked
successfully, then up to 90% of clones should be mutant (according
to Amersham anyway!). The following screening protocols were used
to check for the two mutations:
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a) S11G:
100 plaques were obtained from the transformation with the DNA from
the mutagenesis reaction. Ten of these plaques were picked and
small single-stranded phage preparations were obtained from each
one. Preliminary screening was carried out by C-tracking the ten
clones (i.e. only the C-track of the sequencing reaction was run)
to check for the presence of the two extra C-bands introduced by
the mutation. The celltech oligonucleotide, which hybridised very
close to the area mutagenised, was used as a sequencing primer, and
the sequencing gel was run for only one hour. Although
inconclusive due to the close proximity of the primer to the area
to be sequenced, the C-tracking suggested that at least three of
the clones contained the expected extra bands. These three clones
were sequenced in all four tracks, this time using the
oligonucleotide 342A as a more distant primer and running the gel
for 4.5 hours. All three clones clearly carried the expected
GGA->ACC substitution.
b) K246G:
About 200 plaques were obtained and ten were grown up to provide
ssDNA for sequencing. As this mutation would result in the loss of
three T residues, T-tracking was chosen for preliminary screening
of the clones. The oligonucleotide 181A, which hybridises just
outside the region of mutagenesis, was used as a primer, and the




















Figure o.l. DNA sequence analysis of the SllG and K246G mutants in
phage M13. In each case the corresponding wild-type sequence is
shown on the right of the mutant sequence.
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of the primer, the autoradiograph obtained was not unequivocal, but
it appeared that all ten clones lacked the three T residues. Three
of the clones were sequenced in all tracks, using the universal
primer and running the gel for 3 hours. All three clones carried
the correct mutation TTT->ACC. Autoradiographs of both mutant
sequences, alongside the corresponding wild-type sequences, are
shown in figure 5.1.
These results suggested that mutagenesis had been accomplished with
fairly high efficiency. Direct sequencing of a few clones would
probably yield the required mutant, eliminating the need for
tedious screening procedures.
5.3 Subcloning of the mutants
Both the desired mutant GFM genes had now been created in
bacteriophage Ml3. However, in order to express the mutant enzymes
in yeast it was necessary to subclone the mutated GPM genes back
into a yeast/E.coli shuttle vector. The vector pJDB207 was chosen
as it allowed one simple cloning step, had a very high copy number
in yeast and was available in the laboratory. The disadvantages of
this vector will be discussed later.
Subcloning is summarised in figure 5.2. The first step in
subcloning was to produce double-stranded phage DNA for each mutant
clone. Cells infected with the phage were grown up and a small-
scale plasmid preparation was carried out. The double-stranded DNA
was cut with Hindi 11 and Sail, liberating the mutant GPM gene on a
1.3kbp fragment. After running part of the digest in an agarose



















Figure 5.2. Subcloning strategy for the expression of the S11G and
K246G mutants from the shuttle vector pJDB207.
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phenol/chloroform extraction and ethanol precipitation. The
shuttle vector pJDB207 was also cut with Hindlll and Sail and the
DNA purified. DNA from the two digests was mixed and ligated with
T4 DNA ligase for 2 hours at RT, then transformed into competent
TGI cells and plated out on plates containing ampicillin. From the
restriction maps of the vectors in figure 5.2, the transformants
obtained would consist of the main fragment of pJDB207 with a
Hindlll-Sall insert from MW1 or from the plasmid itself.
Transformants obtained from the ligations were grown up and plasmid
DNA was isolated, then cut with the enzymes Hindlll, Sail and BamHI
and separated in an agarose gel. Clones which had received the
small Hindlll-Sall fragment of pJDB207 would contain one site for
each enzyme, and thus give three bands on the gel. On the other
hand, clones containing the GPM insert would have no BamHI site and
would thus yield only two bands, one of 5.9 kbp corresponding to
the vector and one to the 1. 3kbp GPM insert. In this way plasmids
consisting of the shuttle vector pJDB207 with inserts carrying each
of the mutant GPM genes were obtained and identified. These
plasmids were designated pJDBGlyll and pJDBGly246.
5.4 Transformation of DBYgpm- with pJDBGlyll and pJDBGly246
The next step towards the expression of the two mutant GPM enzymes
in yeast was the transformation of DBYgpm- with pJDBGlyll and
pJDBGly246. Maxi-preparations of the two plasmids were prepared on
caesium chloride gradients, yielding about 500pg of each - more
than sufficient for yeast transformation. Initially a simple LiAc
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transformation of DBYgpm- was attempted, using lOpg of plasmid, and
transformed cells were plated out on YOGE leu- plates to select for
the ability to synthesise L-leucine, as the plasmids contained the
LEU2 marker gene. Although in theory this protocol should yield up
to 103 tranformants/ug DNA, no transformants were obtained from
several repeated experiments. Clearly, one or more factors were
adversely affecting the transformation efficiency. Several
possibilities existed:
Firstly, it was possible that the strain DBYgpm- transformed
poorly, as transformation efficiencies vary to a large extent from
strain to strain. Although the parental strain DBY747 could be
transformed without difficulty the deletion of the GFM gene, and
the subsequent necessity to grow the cells using a glycerol/ethanol
carbon source, might have altered the cell physiology, making
transformation more difficult to acheive.
Secondly, the' vector pJDB207 was known to possess a defective
allele of the LEU2 gene, leu2d. This results in lower levels of
expression of the gene product in cells containing this allele
(Erhart and Hollenberg, 1983) and has two major consequences. On
the plus side, the plasmid is forced to maintain a high copy number
so that enough of the enzyme is produced; and this will result in
high copy numbers for any extra genes inserted into the plasmid.
On the minus side however, freshly transformed cells take much
longer to attain a LEU+ phenotype and will not grow if challenged
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with leu- conditions too soon after transformation. This drawback
could be overcome by incubating transformants overnight in leu+
SOS media at 30°C before plating out.
Thirdly, the media used for the selection of transformants, YOGE
leu- agar, constituted very poor growth conditions for yeast. This
media was required in order to select for recipients of a LEU+
plasmid whilst not presupposing that any active phosphoglycerate
mutase would be present. GPM+ LEU+ cells such as DBY747
transformed with YEP13.GPM grew very slowly on this media, so
newly-transformed cells might have found it hard to establish
growth at all, or might have grown very slowly indeed. If the
mutant 'GPM genes carried by pJDBGlyll and pJDBGly246 coded for
active enzyme, then transformants could be selected for the
restored ability to utilise glucose by plating out on rich ID
medium.
In order to address these three problems and to maximise
transformation efficiency, the spheroplast transformation protocol
of Burgers and Percival (1987, section 2.2.9.1) was used to
transform DBYgpm- with lOpg of each plasmid. The transformants
were kept at 30° C in SOS media supplemented with leucine overnight
and then plated out, half in YD regeneration agar and half in YOGE
leu- regeneration agar. Plates were incubated at 30° C until
colonies were visible. The results are summarised in Table 5.1.
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Table 5.1. Results of spheroplast transformation.
Plasmid YD agar YOGE leu- agar
pJDBGly246 7 colonies 0
after 9 days.
pJDBGlyll 0 2 colonies
after 19 days.
5.5 Analysis of yeast transformants
The transformants obtained were first tested to ensure that they
exhibited the correct phenotype. All grew on Y"D, YOGE leu- and Y'OD
leu- plates and media, although the pJDBGlyll transformants took
noticeably longer to grow on media containing glucose than cells
containing either the wild-type or K246G phosphoglycerate mutase
(see sections 5.6 and 5.7). In order to ensure that the
transformants contained the expected plasmids, the plasmids were
rescued from all the transformants and used to transform competent
TGI cells. In E.coli pJDB207 confers resistance to ampicillin.
Resistant colonies were grown up and plasmid purifications were
carried out. The plasmids obtained were then digested with Hindlll
and Sail and run in an agarose gel with size markers. In every
case the restriction pattern observed matched that expected for
pJDBGlyl 1/246, i.e. two bands of 5.9 and 1.3 kbp (refer to figure
5.2). Finally, to ensure that the yeast transformants carried the
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and one Gly246 transformant were denatured by heating and
transferred onto duplicate Hybond-N filters using a slot-blot
apparatus. As a negative control the plasmid YEP13.GFM, coding for
wild-type GPM, was included; the plasmids pJDBGlyll and pJDBGly246
originally used to transform DBYgpm- were used as positive
controls. The duplicate filters were then probed, one with
labelled S11G oligonucleotide and the other with labelled K246G
oligonucleotide. After hybridization, the filters were washed in
6xSSC at RT and autoradiographed for 4 hours at -70° C. The
autoradiographs are shown in figure 5.3. Under these conditions
hybridisation was quite nonspecific, and the oligonucleotides did
not greatly differentiate between the various plasmids. The
filters were then rewashed in 6xSSC at 47° C, which was 7 and 5°C
below the Td's calculated for the oligonucleotides S11G and K246G
respectively, and autoradiographed overnight at -70°C. At this
stringency, the oligonucleotides would be expected to hybridise
only to sequences which were a perfect match. As shown in figure
5.3, the oligonucleotide S11G hybridised only to the original and
rescued pJDBGlyll plasmids whilst the K246G oligonucleotide









Figure 5.3. Slot-blot analysis of the S11G and K246G mutant GPM
genes expressed from pJDB207 rescued from the yeast strain DBYg'pm-.
al - YEP13.GPM; bl - pJDBGlyll; b2 - pJBBGlyll rescued;
cl - pJDBGly246; c2 - pJDBGly246 rescued.
Experimental details are described in the text.
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5.6 Expression levels of wild-type and mutant phosphoglycerate
mutases
In order to assess the levels of expression of phosphoglycerate
mutase in the yeast strain DBYgpm- transformed with YEP13.GPM,
pJDBGlyll and pJDBGly246, crude cell extracts were analysed by SDS-
PAGE. Figure 5.4 shows the levels of expression observed. Wild-
type phosphoglycerate mutase is expressed from the vector YEP13 at
fairly high levels, being the most highly expressed protein in the
cell extract. This was also observed by Kawasaki and Fraenkel
(1982) when YEP13.GPM was originally isolated by complementation,
and is due to gene amplification caused by the multi-copy pl&.sr<u<^ .
The vector pJDB207 also has a high copy number in yeast, and the
mutant S11G is overexpressed from the vector pJDB207 in DBYgpm-,
although at around half the level observed for the wild-type
enzyme. In contrast, the mutant enzyme K246G does not appear to
have a high level of expression from pJDB207, and may be present at
levels lower than those obtained from a single chromosomal copy of
the wild-type gene (compare with figure 6.1)
Why are the two mutant enzymes, especially K246G, expressed at
lower levels than the wild-type? The answer may lie in the length
of yeast DNA present upstream of the GPM coding region. In
YEP13.GPM several kilobases of upstream flanking sequence is
present (figure 3.2), whereas for the constructs pJDBGly11 and
pJDBGly246 only about 500 bases of upstream DNA are included
(figure 5.2). It is possible that an upstream activating site
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4. DBYgpxn- + pJDBGlyl 1
5. DBYgpm- + pJBBGl.y246
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expression levels. UAS's have been observed for several yeast
genes, often considerably distant from the coding sequence
(Guarente, 1984). This theory is supported by the work of Rodicio
and Heinisch (1987), who found that expression of phosphoglycerate
mutase from a multicopy plasmid decreased markedly when a region of
DNA between the EcoRI and Hindlll sites immediately upstream of the
gene was removed (see figure 3.2 for restriction map). In the
constructs pJDBGlyll and pJDBGly246, the upstream DNA terminates at
the Hindlll site, so it is possible that a UAS is present between
the EcoRI and Hindlll sites.
Why is the mutant K246G expressed at such low levels relative to
the S11G enzyme, when both are expressed from the same plasmid, and
have the same flanking sequences? It is possible that the
particular clones chosen for the two mutants displayed differing
expression levels due to variations in plasmid copy number, however
the seven pJDBGly246 transformants screened all had very low levels
of expression. One other possibility is that cells derive a
selective advantage from the overexpression of the S11G mutant, for
example if the enzyme had a very low activity. The inability to
obtain pJDBGlyll transformants on media containing glucose could be
due to the enzyme being barely catalytically competent. Yeast
cells expressing the mutant enzyme S11G, and dependent on that
enzyme for the utilization of glucose, were consistently observed
to grow more slowly in media containing glucose than cells
expressing the wild-type or K246G phosphoglycerate mutases. If this




In order to further investigate the growth characteristics of the
strain DBYgpm- expressing the wild-type and two mutant enzymes,
growth curves were determined for the three strains in YD media
(standard media containing glucose as carbon source) by measuring
the increase in optical density at 600nm of triplicate 100ml
cultures. Each culture was inoculated at time zero with an equal
volume of a starter culture which had been grown to an OD6 o o of
1.0. The data are presented graphically in figure 5.5. Initially
all cultures exhibited a lag phase; cells expressing the K246G
enzyme were the first to enter exponential growth, followed closely
by those expressing wild-type phosphoglycerate mutase. The
slightly slower growth of cells with the wild-type phosphoglycerate
mutase may be a consequence of the involvement of the synthetic
machinery in maintaining the high level of expression of the enzyme
observed in these cells. The strain expressing the S11G mutant
displayed a considerably longer lag phase before entering log
phase, but once in log phase appeared to be able to grow as quickly
as the other strains. In a separate experiment, the level of
expression of the S11G enzyme in DBYgpm- was analysed by SDS-PAGE
during lag, exponential and stationary phases, and no significant
changes were observed (data not shown). Further growth experiments
together with measurements of the flux through glycolysis and of





Figure 5.5. Growth curves for DBYgpm- transformed with YEP13.GPM,
pJDBGlyll and pJDBGly246. Data points are the means of
triplicates, and standard deviations are indicated.
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In summary, two mutant forms of the enzyme phosphoglycerate mutase
were designed, constructed and expressed in the yeast strain
DBYgpm-. The fidelity of each mutation was confirmed in the
respective transformed yeast cells, and expression levels were
analysed. A preliminary investigation of the growth
characteristics conferred by these enzymes was carried out. The
purification and characterisation of the two mutant enzymes were
now possible.
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6. Purification of wild-type and mutant phosphoglycerate mutases
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6.1 Background
The purification of yeast phosphoglycerate mutase was first reported
over thirty years ago (Rodwell et al., 1956). Methods have
continually been updated in line with advances in protein purification
technology. The most recent relevant advance has been the
introduction of affinity chromatography. It was discovered that the
cofactor-dependent phosphoglycerate mutases, in common with many other
glycolytic enzymes, would bind to a column of cibacron-blue Sepharose
and could be specifically eluted using the substrates or cofactor. A
final affinity chromatography step involving binding to cibacron-blue
or other dyes such as cibacron-red-3BA (Pawluk et al., 1986) has been
adopted in most of the more recent purification protocols for
phosphoglycerate mutase from various sources including Leuconostoc
(Kawai et al., 1981), S.cerevisiae (Price and Stevens, 1983), S.pombe
(Price et al., 1985), pig heart (Pons and Cameras, 1985) and
Z.mobilis (Pawluk et al., 1986).
6.2 Specific considerations
Historically, there has been no shortage of source material for the
purification of yeast proteins. An obliging brewery could be relied
on to provide yeast (an unwanted by-product) by the kilogram.
Protocols for the isolation of yeast phosphoglycerate mutase
typically start with several hundred grams wet weight of yeast and end
up with several hundred mg of pure enzyme. For the purposes of this
project, a much smaller scale of purification was both necessary and
desirable. The use of transformed strains limited the amount of yeast
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available to that which could be grown up in the laboratory; typically
from 2-3 litres of culture at any one time. Hopefully, the
overexpression of the enzyme from a plasmid would allow a higher yield
of phosphoglycerate mutase per gram wet weight of cells. In any
case, for the purposes of kinetic analysis as little as 300}jg of pure
enzyme would be sufficient. A simple, scaled-down protocol for the
purification of wild-type phosphoglycerate mutase was thus devised.
6.3 Purification of phosphoglycerate mutase
Initially, cells of the yeast strain DBYgprn- transformed with the
vector YEP13.GFM, and thus overexpressing wild-type phosphoglycerate
mutase (figure 5.4), were lysed overnight in 1M ammonia according to
the method of de la Morena et al., (1968). The lysate was then
subjected to a 55-70% saturated ammonium sulphate fractionation,
dialysed overnight, and applied to a cibacron blue-Sepharose column.
After a NADH/AMP wash, phosphoglycerate mutase was eluted from the
column by washing with a step of lOmM 3-PGA. When the purified
protein was analysed by SDS-PAGE two bands of roughly equal intensity
were apparent. The specific activity of the sample was about half
that expected for pure phosphoglycerate mutase in the enolase-coupled
assay (Price and Jaenicke, 1982). The two bands had apparent Mr's of
30,000 and 28,000. The more mobile protein exhibited the expected
subunit size for yeast phosphoglycerate mutase and coincided with the
protein overexpressed in crude extracts of yeast transformed with
YEP13.GPM (figure 5.4). The contaminating protein thus appeared to be
the larger of the two. The sample gave a single peak on HPLC (not
shown) and yielded a single N-terminal protein sequence for the two
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components corresponding to yeast phosphoglycerate mutase, indicating
either an identical N-terminal sequence or a blocked N-terminus for
the contaminating protein.
Proteolytic degradation during autolysis of yeast phosphoglycerate
mutase has been well documented (Sasaki et al., 1976), and is thought
to arise from the removal of successive amino acids from the C-
terminus of the protein. The loss of about ten residues from the C-
terminus of rabbit muscle phosphoglycerate mutase does not affect the
binding or elution properties of the enzyme on a cibacron blue-
Sepharose column (Price et al., 1983). However loss of all or part of
the tail would be expected to yield smaller, more mobile bands on an
SDS-PAGE gel whilst the contaminant in this case appeared to be
larger. %
Despite the anomalous observations from denaturing gels, the loss of
the C-terminal tail during cell lysis remained the most likely
explanation. Accordingly, a new method of cell lysis was introduced,
as detailed in section 2.2.12.1 of the methods. The method was very
fast, minimising the opportunities for proteolysis, and the protein
was then purified as before. This procedure yielded a single band of
Mr about 28,000 in SDS-PAGE (figure 6.1). The specific activity of
the enzyme matched that reported by Price and Jaenicke (1982). The
purification is summarised in table 6.1.
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Figure 6.1. SDS-PAGE analysis of the purification of the wild-type and
mutant forms of phosphoglycerate mutase from yeast.
1. markers
2. DBY747
3. purified K246G phosphoglycerate mutase
4. rabbit muscle phosphoglycerate mutase
5. pure wild-type phosphoglycerate mutase from modified procedure
6. autolysed wild-type phosphoglycerate mutase (two bands not clearly
separated)
7. partly purified S11G phosphoglycerate mutase
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Table 6.1. Purification of wild-type phosphoglycerate mutase.
The label 'crude' represents the initial cell extract; 'dial.'
represents the sample after ammonium sulphate fractionation and
overnight dialysis; 'column' represents the protein sample eluted from
the cibacron blue-Sepharose column by 3-phosphoglycerate.
sample volume protein EU sp.act. yield purifn.
(ml) (mg) (EU/mg) (%) (fold)
crude 82 3600 72200 20 100 1
dial. 2.0 77 59500 780 82 39
column 10.6 3.0 22500 7500 31 375
6.4 Purification of K246G
The mutant K246G was purified from the strain DBYgpm- transformed with
pJDBGly246 using the same method as for the wild-type enzyme. As
expected, the mutation introduced in the C-terminal tail did not alter
the physical properties of the enzyme with respect to purification.
Due to a much lower level of expression of this mutant (section 5.5
and figure 5.4), a lower yield of pure enzyme per g wet weight of
cells was obtained. The purification of K246G is summarised in table
6.2. When analysed by gel densitometry, the enzyme appeared about 90%
pure, with a minor amount of one contaminating protein (figure 6.1).
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Table 6.2. Purification of K246G.
The samples are labelled as for table 6.1.
sample volume protein EU sp.act. yield purifn.
(ml) (mg) (EU/mg) (%) (fold)
crude 86 1700 9240 5.4 100 1
dial. 3.3 85 2640 31 29 6
column 5.6 0.33 1960 6000 21 1100
6.5 Purification of S11G
The mutant enzyme S11G appeared to be significantly over-expressed in
DBYgpm- transformed with pJDBGlyll (see figure 5.4). However, these
cells grew significantly slower in YEPD medium than cells expressing
either the wild-type or K246G enzymes. Purification of this mutant
was at first attempted using the same method as for the other two
enzymes, but problems of enzyme instability soon became apparent.
Firstly, a drop in activity of about 20% per day was observed when the
partly-purified enzyme was stored in 80% saturated ammonium sulphate
at 4°C; conditions in which the wild type enzyme was stable
indefinitely. The enzyme also lost a significant proportion of its
activity when dialysed overnight against lOmM Tris-HCl pH7.5. The
main problem however came at the affinity chromatography step.
Despite repeated attempts, none of the enzyme activity loaded onto the
cibacron blue-Sepharose column was ever recovered, neither in the
wash-through nor in the NADH/AMP, 3-PGA or NaCl eluents. When samples
of the eluents irere ruA on SDS-PAGE, large amounts of protein
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degradation products were observed. An attempt to further purify the
protein by FPLC on a Superose-12 column also failed to yield any
active enzyme. Because of the evident instability of the enzyme, and
pressures of time, it was decided to use a partly-purified enzyme
preparation for the kinetic analyses. In order to maximise the degree
of purification whilst avoiding gel chromatography, a stepped ammonium
sulphate fractionation was carried out. Cells were lysed, made 55%
ammonium sulphate saturated, and spun as before, with the omission of
the heating step. The protein was fractionated by successively
increasing the degree of ammonium sulphate saturation by 5%,
centrifuging, and assaying the specific activity of the enzyme in the
pellets obtained. The purification table is shown below.
Table 6.3. Purification of S11G.
The sample labelled 'crude' represents the total cell extract whilst
the other samples are denoted by the fraction of ammonium sulphate
saturation in which they precipitated.
sample volume protein EU sp.act. yield purifn.
(ml) (mg) (EU/mg) (%) (fold)
crude 53 345 200 0.58 100 1.0
55-60AS 0.5 14.3 8.5 0.59 4 1.0
60-65 0.7 13.6 34. 2.5 17 4,3
65-70 0.8 15.0 91. 6.1 46 11
70-75 0.8 15.2 102 6.7 51 12
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The fraction with the highest specific activity was found to be that
which precipitated between 70 and 75% saturated ammonium sulphate. It
was resuspended in 80% saturated ammonium sulphate and 2,3-BPGA, which
is known to stabilise the wild-type enzyme, was added to a final
concentration of ImM. When stored under these conditions at 4°C, the
enzyme activity did not decrease significantly over several weeks.
The enzyme was also stable under the conditions of the standard
enolase-coupled assay for at least 30 min. Analysis by SDS-PAGE and
densitometry showed that the S11G enzyme was about 25% pure in this
fraction (see figure 6.1). This factor was taken into account in all
subsequent kinetic experiments.
In summary, a procedure which allowed the rapid, small-scale
purification of yeast phosphoglycerate mutase to homogeneity was
developed and utilised to purify both the wild-type and K246G enzymes
to allow kinetic analyses. The S11G mutant appeared to be inherently
unstable, especially in dilute solutions, and only partial
purification was achieved. The reason for this instability is
unclear, but may be due to an increase in the flexibility of the




This chapter describes the kinetic analysis of the purified wild-type
and K246G enzymes and the partly-purified S11G enzyme. The kinetic
parameters which were measured were:
a) The Km's for 3-PGA, 2-PGA and 2,3-BPGA.
b) The catalytic constants for the mutase, synthase and phosphatase
activities.
All measurements for Michaelis constants were carried out in
triplicate and standard deviations were calculated. Estimates of the
Michaelis constants were made using non-linear regression analysis
with weighting based on the standard deviations of each data point,
using a program developed by Duggleby ( 1984). The data for the
Michaelis constants are presented graphically as Hanes plots using the
program CRICKETGRAPH on an Apple Macintosh microcomputer. The
catalytic constants were calculated from three separate experiments
assuming a subunit molecular mass of 27.5 kDa, and for the mutant S11G
have been corrected based on a calculated purity of 25% obtained from
gel densitometry.
7.1 Km for 3-phosphoglycerate
The Km for the glycolytic substrate 3-phosphoglycerate was measured
using an assay coupled through enolase, PK and LDH to the oxidation of
NADH as described in section 2.2.13.1. The concentration of the
cofactor 2,3-bisphosphoglycerate was constant at O.lmM for the wild-
type and K246G, and at 0.2mM for the S11G enzymes. The enzyme
activity was measured at five or six concentrations of
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3-phosphoglycerate. The data are plotted in a Hanes plot (figure
7.1), and the estimates obtained for the Michaelis constants are
summarised in table 7.1.
Table 7.1. Estimation of the Km's for 3-phosphoglycerate.
enzyme Km 3-PGA (pM) standard error no. of data points
wild-type 510 + 60 6
K246G 590 + 100 6
S11G 720 + 40 5
The values obtained for the Km for 3-PGA of the wild-type and mutant
enzymes agree well with the value of 710p_M previously determined for
the wild-type enzyme from yeast (McAleese et al., 1985).
7.2 Km for 2-phosphoglycerate
The Km for the gluconeogenic substrate 2-phosphoglycerate was measured
using an assay coupled through PGK and GAPDH to the oxidation of NADH,
as described in section 2.2.13.2. The concentration of the cofactor
was as described in section 7.1 above. The enzyme activity was
measured at five or six concentrations of 2-phosphoglycerate, and the
data are plotted in a Hanes plot (figure 7.2). The estimates
obtained for the Michaelis constants are summarised in table 7.2.
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Table 7.2. Estimation of the Km's for 2-phosphoglycerate.
enzyme Km 2-PGA (pM) standard error no. of data points
wild-type 52 ±7 5
K246G 72 +5 6
S11G 59 +16 5
These values agree with the estimate for the Km for 2-PGA of <100pM
previously determined for the wild-type yeast enzyme (Rodwell et al.,
1957).
7.3 Km for 2,3-bisphosphoglycerate
The Km for the cofactor 2,3-bisphosphoglycerate was determined using
an assay coupled through the enzymes enolase, PK and GAPDH to the
oxidation of NADH, as described in section 2.2.13.1. The
concentration of the substrate 3-PGA was constant at lOmM. The enzyme
activity was measured at five concentrations of 2,3-BPGA, correcting
for the presence of low amounts of 2,3-BPGA in the enzyme samples and
in the 3-PGA, and the data were plotted in a Hanes plot (figure 7.3).
The apparent Km values obtained for the wild-type, K246G and S11G
enzymes are summarised in table 7.3.
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Table 7.3. Estimation of the Km's for 2,3-bisphosphoglycerate.
enzyme Km 2,3-BPGA (^aM) standard error no. of data points
wild-type 5.5 ±_ 0.9 5
K246G 3.3 + 0.6 5
S11G 49 + 16 5
These compare with a value of 14pM previously determined for the wild-
type yeast enzyme under similar conditions and with the same
concentration of 3-PGA (Johnson and Price, 1987). At this
concentration, 3-PGA will compete with 2,3-BPGA for binding sites on
the enzyme, raising the apparent Km value for the cofactor. Using
low, non-competitive concentrations of 3-PGA, the Km for 2,3-BPGA of





Figure 7.1. Hanes plot showing the Km for 3-phosphoglycerate of the
wild-type, S11G and K246G forms of phosphoglyeerate mutase. Hie





Figure 7.2. Hanes plot showing the Km for 2-phosphoglycerate of the
wild-type, S11G and K246G forms of phosphoglycerate mutase. The





Figure 7.3. Hanes plot showing the Km for 2,3-bisphosphoglycerate of
the wild-type, S11G and K246G forms of phosphoglycerate mutase. The




The catalytic constants of the three enzymes for the phosphoglycerate
mutase activity in both the glycolytic ('forward') and gluconeogenic
('reverse') directions were determined using the assays described in
sections 2.2.13.1 and 2.2.13.2, respectively. Maximal activity in
the forward direction was observed with a concentration of lOmM 3-PGA,
and in the reverse direction with a concentration of 400pM 2-PGA. At
higher concentrations, substrate inhibition was observed, probably due
to the competition of substrate with cofactor at the active site. The
values obtained are summarised in table 7.4.
Table 7.4. Catalytic constants for the phosphoglycerate mutase
reactions in the forward and reverse directions.
All values are the means obtained from three separate experiments, and
standard deviations are indicated.















The 2,3-bisphosphoglycerate synthase activities of the three enzymes
were measured using an assay which continually regenerated the
substrate 1,3-bisphosphoglycerate, thus avoiding the problems of
instability of this molecule. The amount of 2,3-BPGA formed was
estimated by measuring its ability to stimulate the phosphoglycerate
mutase reaction (section 2.2.13.3). The values obtained in this way-
were assumed to represent maximal velocities for the synthase
activities of the three enzymes, and are presented in table 7.5.
Table 7.5. Catalytic constants for the 2,3-bisphosphoglycerate
synthase activity.
All values are the means obtained from three separate experiments, and
standard deviations are indicated.
enzyme catalytic constant (s- 1 )
These values are in good accordance with the only other reported
measurement of yeast phosphoglycerate mutase synthase activity, of









The 2,3-bisphosphoglycerate phosphatase activity of the three enzymes
was determined in the presence and absence of the activator 2-
phosphoglycollate as described in section 2.2.13.4, and are summarised
in table 7.6.
Table 7.6. Catalytic constants for the 2,3-bisphosphoglycerate
phosphatase reaction.
All values are the means obtained from three separate experiments, and
standard deviations are indicated.
enzyme catalytic constant (s~1) stimulation
basal stimulated (fold)
wild-type 0.0065 +_ 0 0.080 +_ 0.003 12
K246G 0.0067 +0.0004 0.100 +0.002 16
S11G 0.00049 + 0.00003 0.0042 + 0.0001 9
7.7 Wild-type phosphoglycerate mutase
The purified wild-type enzyme had kinetic characteristics similar to
those previously reported for both yeast and mammalian
phosphoglycerate mutases. The ratio of the mutase (forward) :
synthase : phosphatase (basal) activities was 1000:0.06:0.02, which is
in good agreement with the ratios previously reported of
1000:0.03:0.02 for yeast (Sasaki et al., 1976); 1000:0.1:0.06 for pig
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muscle and 1000:0.06:0.05 for cat muscle phosphoglycerate mutase (Pons
et al., 1985). The ratio for the mutase : phosphatase activities of
the rabbit M-type enzyme has also been measured by 31P-NMR, which
yielded a ratio of 1000:0.06, confirming the kinetic results (Robinson
et al., 1984). Calculation of the substrate specificity using the
value kcat/Km yields values of 7.5xl05 s-1mol~1 for 3-phosphoglycerate
and lxlO7 s-1mol_ 1 for 2-phosphoglycerate. This indicates that as a
substrate, 2-phosphoglycerate is preferred over 3-phosphoglycerate by
a factor of 13.
7.8 K246G phosphoglycerate mutase
The mutant enzyme K246G displayed affinities for 3-PGA, 2-PGA and 2,3-
BPGA which differed only slightly from those observed for the wild-
type enzyme. The catalytic constants for the forward and reverse
mutase reactions were about 15% lower than for the wild-type enzyme,
whilst the synthase activity was slightly higher and the basal
phosphatase activity about the same. The increased stimulation of the
phosphatase activity observed for K246G in the presence of 2-
phosphoglycollate may be significant, or may be a reflection of
differing proportions of 'tailed' and 'tail-less' enzyme in the two
preparations (see section 1.11). The ratio of mutase : synthase :
phosphatase activities was 1000:0.1:0.02 - similar to that reported
for other phosphoglycerate mutases. Overall, the loss of the C-
terminal lysine appears to have had little effect on the kinetic
parameters of phosphoglycerate mutase. The isolation and resequencing
of the mutase gene from the yeast which have been used as a source of
the mutant enzyme will be essential, in order to ensure that no
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spurious mutations have occured. The possibility of contamination by
another strain of yeast, which would result in a similar kinetic
profile to that ascribed to the K246G enzyme, must also be rigorously
excluded. With these provisos, our ideas about the functional
significance of the tail in general, and the two C-terminal lysines in
particular, may have to be revised.
7.9 S11G phosphoglycerate mutase
The replacement of serine 11 with a glycine residue appears to have
resulted in dramatic changes in the kinetic characteristics of the
mutant phosphoglycerate mutase. These are discussed individually
below. It should be emphasised that the kinetic results are based on
an enzyme which is only about 25% pure; obviously further purification
will be necessary. Again, until the mutase gene is resequenced from
the yeast which have been used as a source of the mutant enzyme, the
possibility of spurious mutations cannot be ruled out, and the
following discussion must be read with this reservation in mind.
a) Affinity constants
The affinity for the cofactor 2,3-bisphosphoglycerate appears to have
been decreased by a factor of about ten with respect to the wild-type
enzyme. This may confirm the suspected role of serine 11 in the
binding of the cofactor, probably as a phospho-ligand for the
transferrable phospho-group. As discussed in section 1.10.1, the
affinities of E isoenzymes for 2,3-bisphosphoglycerate are much lower
than those of their corresponding M and B isoenzymes. This could be
mainly due to the lack of the serine 11 phospho ligand in the E
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isoenzymes. The affinities for the substrates 2- and 3-
phosphoglycerate appear little changed by the S11G substitution,
suggesting that serine 11 plays no part in their binding at the active
site of the enzyme. During catalysis, the mono-phosphorylated
substrates are thought to bind to the catalytically active
phosphorylated form of the enzyme (section 1.8.3). If this were the
case, then serine 11 would not be expected to be involved in their
binding.
b) Mutase and Phosphatase activities
The phosphoglycerate mutase activity of the S11G enzyme appears to
have decreased by 99.5% for the forward direction and by 99.8% for
the reverse direction with respect to the wild-type enzyme. This
dramatic loss of activity does not appear to have been disastrous to
the yeast strain expressing this enzyme, which can still utilise
glucose as sole carbon source - although it does have a noticeably
longer lag phase (section 5.7). Estimating that the enzyme is over-
expressed by a factor of ten in this strain (fig. 5.4), then only 2-5%
of the normal mutase activity is present in these cells. This
observation points to a large excess of catalytic capacity for
phosphoglycerate mutase in normal yeast cells.
The large drop in the mutase activity is probably due to a large
decrease in the rate of phosphorylation of the enzyme by 2,3-
bisphosphoglycerate. This rate has been shown to be very fast for
chicken muscle phosphoglycerate mutase (>1000s-1), but much slower for
the horse erythrocyte bisphosphoglycerate mutase (2.3s-1) (Rose and
Dube, 1976). The catalytic constant of the S11G mutant for the mutase
reaction of 2.1 s-1 agrees well with the observed rate of
141
phosphorylation of the synthase enzyme of 2.3s*1, suggesting that
phospho-transfer from 2,3-bisphosphoglycerate to the enzyme may be the
rate-limiting step in the mutase reaction catalysed by the S11G
mutant.
Another intriguing observation is that the ratio of the maximal
activities of the mutase reaction in the glycolytic (forward) and
gluconeogenic (reverse) directions has shifted from f/r=0.74 for the
wild-type enzyme to f/r=2.1 for the S11G mutant. This change can not
be accounted for by a change in the relative affinities for 2- and 3-
phosphoglycerate, which appear more or less unaltered. In the
mechanism postulated for the mutase reaction, as described in section
1.9.1 and figure 1.8, catalysis is initiated by phospho-transfer from
the enzyme to bound 3-phosphoglycerate (for the forward direction) or
2-phosphoglycerate (for the reverse direction). It could be possible
that the S11G replacement has affected these two phospho-transfer
steps to differing extents, making the transfer to 3-phosphoglycerate
more favourable at high concentrations of substrate. It is worth
noting that, using the value kcat/Km as a measure of substrate
specificity, 2-phosphoglycerate is still the more favoured substrate
by a factor of about 6 over 3-phosphoglycerate.
The basal 2,3-bisphosphoglycerate phosphatase activity of the S11G
mutant is only 8% of that observed for the wild-type enzyme. The rate
of this reaction is much lower than that of the mutase reaction, and
is therefore probably not limited by the common step of
phosphorylation of enzyme by cofactor. It may instead be limited by
the rate of phospho-transfer from the enzyme to an acceptor molecule
such as water. The phosphatase activities observed for the chicken
and human E isoenzymes are about 10% of those found in their
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respective B isoenzymes (Bosch et al., 1982; Ikura et al., 1978).
c) Synthase activity
The 2,3-bisphosphoglycerate synthase activity of the S11G mutant does
not appear to differ significantly from that of the wild-type enzyme.
In this reaction, 1,3-bisphosphoglycerate phosphorylates the enzyme in
a step which is probably rate-limiting for both B and E isoenzymes
(Rose and Dube, 1976). The loss of the serine 11 ligand has therefore
probably neither increased nor decreased the rate of phospho-transfer
from 1,3-bisphosphoglycerate. As already mentioned (section 1.10.1), E
isoenzymes have a tenfold higher affinity for 1,3-bisphosphoglycerate
than B or M isoenzymes, giving rise to a correspondingly higher rate
of phospho-transfer, and therefore synthase activity. Although no
measurements have been made here, it is unlikely that the S11G enzyme
possesses a higher affinity for 1,3-bisphosphoglycerate than the wild-
type.
In summary, a preliminary analysis of the kinetic parameters of the
wild-type and two mutant forms of yeast phosphoglycerate mutase has
been carried out. Hie wild-type enzyme has kinetic characteristics
similar to those found previously for both the yeast enzyme and the
mammalian M and B isoenzymes. The K256G mutant does not appear to
differ!significantly from the wild-type enzyme, suggesting that the C-
terminal lysine is not essential for activity. The S11G mutant
appears to display altered characteristics which may reinforce our
ideas about the molecular basis for the mutase and synthase activities
catalysed by the phosphoglycerate mutase family. Resequencing of the
mutated genes in DBYgpm- remains an essential task.
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8. General Discussion and Future Work
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In the last few years, site-directed mutagenesis has increasingly been
employed to further the degree of our understanding of the molecular
basis for enzyme catalysis. The yeast enzyme phosphoglycerate mutase,
for which the amino acid sequence and crystal structure are known;
and for which a detailed reaction mechanism has been postulated;
presents an ideal target for study by this method. In the work
presented in this thesis, two aspects of the molecular
structure/function relationship for yeast phosphoglycerate mutase have
been studied. These conclusions drawn here must be qualified by the
lack of incontrovertible evidence that the 'mutant' enzymes which have
been studied are in fact identical to those designed. Possiblities
remain that contamination or spurious mutations could account for the
enzyme characteristics observed. Sequencing of the entire mutant GFM
genes as expressed in the yeast from which the mutant enzymes have
been isolated will be required.
Firstly, the importance of the C-terminal lysine residue in the
flexible 'tail' of the enzyme has been probed by replacing it with a
glycine residue to form the mutant enzyme K246G. On the basis largely
of structural evidence, an important role has been ascribed to this
lysine together with its sister lysine in the penultimate position at
the C-terminus. The positive charges associated with these residues
are thought a) to provide a phospho-1igand at the active site in order
to stabilise the enzyme/transition state complex and b) to neutralise
the charge associated with the carboxyl terminus of the enzyme.
However, the mutant K246G appears to have kinetic properties very
similar to those of the wild-type enzyme, indicating that lysine 246
may not be involved in the catalytic mechanism of the enzyme. The
145
possibility remains that lysine 245 is present at the active site and
that the carboxy terminus forms a salt link with a residue near the
active site, helping to anchor the tail during catalysis. Obviously
this interpretation is open to examination by further site-directed
mutagenesis.
Secondly, the close relationship of phosphoglycerate mutase with the
enzyme bisphosphoglycerate mutase (its probable offspring) has been
studied by the creation of a mutant form of the enzyme in which serine
11 has been replaced by a glycine (S11G). Bisphosphoglycerate mutase
has evolved a tendency to release (and therefore synthesize)
2,3-bisphosphoglycerate in preference to the continual recycling of
the compound which is favoured by its progenitor phosphoglycerate
mutase. One of the differences observed at the active sites of the
two enzymes is at residue 11 - a serine in phosphoglycerate mutase,
where it is thought to help bind 2,3-bisphosphoglycerate but a glycine
in bisphosphoglycerate mutase, where it can play no binding role. The
mutant enzyme S11G appears to have a markedly reduced affinity for
2,3-bisphosphoglycerate which results in a low mutase activity,
similar to bisphosphoglycerate synthase and a low synthase activity,
similar to phosphoglycerate mutase. In other words, it may represent
a 'halfway house' or 'hybrid' form of the two enzymes, and be
catalytically incompetent to substitute for either. How could yeast
phosphoglycerate mutase be made a better synthase? The crucial
increase in the synthase activity observed for bisphosphoglycerate
mutase must arise from its higher affinity for the substrate
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1,3-bisphosphoglycerate, and this must be due to other residues near
the active site. If further mutagenesis is to be contemplated with
this aim in mind, then perhaps the best candidate is alanine 60, which
is a serine in bisphosphoglycerate mutase. Would either an A60S
mutant or a S11G/A60S double mutant possess an enhanced synthase
activity? Again, site-directed mutagenesis can provide the answers.
In the near future, other aspects of the structure and activities of
yeast phosphoglycerate mutase will be investigated by site-directed
mutagenesis. Examination of the structural elements important in
determining quaternary structure, and of the role in catalysis of
other residues at the active site of the enzyme, will involve studies
by crystallography, circular dichroism and protein NMR. Preliminary
NMR experiments have indicated that the investigation of the function





i) The gene encoding phosphoglycerate mutase from S.cerevisiae was
localised on the plasmid YEP13.GFM supplied by Dr Dan Fraenkel by the
use of oligonucleotide probes. The gene was subcloned into phage M13
and sequenced by dideoxy sequencing.
ii) The chromosomal copy of the GPM gene was deleted from the yeast
strain DBY747 and replaced with the marker gene HIS3, creating the
strain DBYgpnr.
iii) Two mutant forms of the enzyme phosphoglycerate mutase,
incorporating the replacements serine 11 to glycine (S11G) and lysine
246 to glycine (K246G) were designed and constructed using site-
directed mutagenesis.
iv) The wild-type and two mutant forms of phosphoglycerate mutase were
expressed in the GFM-deleted yeast strain DBYgpnr from shuttle
vectors.
v) The wild-type and K246G enzymes were purified to homogeneity. Due
to problems of instability, the S11G enzyme was only partly purified.
vi) Kinetic analyses of the three enzymes was carried out. The
effects of the mutations introduced, and their significance towards an
understanding of the structure/function relationship of
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Sequence of the gene encoding phosphoglycerate mutase from
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The gene encoding yeast phosphoglycerate mutase was isolated, and its sequence was determined. The gene specifies a
protein of 246 amino acids, and contains no introns. The sequence shows a strong codon bias. The upstream untranslated
portion of the gene contains a CT-rich block such as is found in many highly expressed yeast genes, but does not have
the associated CAAG sequence.
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1. INTRODUCTION
Phosphoglycerate mutases comprise a family of
enzymes which catalyse reactions involving the
transfer of phospho groups among the three car¬
bon atoms of phosphoglycerates. There are at least
five types of phosphoglycerate mutase that are
kinetically and structurally distinct, but never¬
theless have many features in common (e.g. see
[1-3]). The enzyme from Saccharomyces
cerevisiae has been extensively characterized, and
the high-resolution crystallographic structure and
amino acid sequence have been reported [4,5], We
present here the isolation and sequence determina¬
tion of the gene encoding this enzyme, as a prere¬
quisite for protein engineering studies to
investigate its mode of action.
2. EXPERIMENTAL
The gene encoding S. cerevisiae phosphoglycerate mutase
Correspondence address: L.A. Fothergill-Gilmore, Department
of Biochemistry, University of Edinburgh, George Square,
Edinburgh EH8 9XD, Scotland
The nucleotide sequence presented here has been submitted to
the EMBL/GenBank database under the accession number
X06408
(GPM) has been obtained in the multicopy plasmid YEpl3 by
complementation [6], and was kindly given to us by D.G.
Fraenkel. A restriction map of the plasmid was constructed,
and the coding sequence was located with the use of
oligonucleotide probes. A HindlU/Satl restriction fragment
containing the entire coding region together with several hun¬
dred base pairs of flanking sequences was subcloned into phage
M13 for sequence determination by the dideoxy method. The
use of the Sequenase DNA sequencing kit (US Biochemical
Corp., Cleveland, OH) allowed sequences of about 500 bases to
be determined from a single primer.
3. RESULTS AND DISCUSSION
3.1. Restriction mapping of YEpl3-GPM
Restriction mapping of the recombinant YEpl3
plasmid revealed an insert of 6 kbp of S. cerevisiae
chromosomal DNA (fig.l). The phosphoglycerate
mutase coding sequence was located within this in¬
sert by Southern blotting with two end-labelled
oligonucleotides corresponding to the N- and C-
terminal regions of the protein sequence. Both
oligonucleotides hybridized specifically to a
1.3 kbp Hindlll/Sall restriction fragment which
was therefore subcloned into phage M13mpl9 for
sequencing.
3.2. Nucleotide sequence of GPM gene
The strategy used to sequence the
phosphoglycerate mutase gene is summarised in
Published by Elsevier Science Publishers B. V. (Biomedical Division)
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Volume 229, number 2 FEBS LETTERS March 1988
fig.l. A contiguous stretch of 1154 bases was se¬
quenced which includes an open reading frame of
741 bases encoding the enzyme phosphoglycerate
mutase (fig.2). The DNA sequence largely agrees
with the previously determined protein sequence,
and the differences are discussed below.
Phosphoglycerate mutase is typical of glycolytic
enzymes in yeast in being highly expressed. Like
other highly expressed yeast genes [7], GPM ex¬
hibits an extreme codon bias. Only 31 codons are
used, and of these 24 account for 93% of the
amino acids (phosphoglycerate mutase has no cys¬
teine residues). This compares with values of 94%
for phosphoglycerate kinase, 95% for enolase I
and 95% for alcohol dehydrogenase I. The
upstream flanking sequence also has features
similar to those of other highly expressed yeast
genes. These include A residues at -1 and -3,
and a 44 base A-rich region containing no G
residues immediately adjacent to the initiating
ATG codon [8]. Another feature found in many
highly expressed yeast genes is a CT-rich block,
here present at - 83 to -109, but there is no
associated CAAG sequence [9], A TATA box at
position — 138 may be involved in the initiation of
transcription, and the sequence CACACA at posi¬
tion -16 is found in several other yeast genes
although its function is not known [9]. The
downstream flanking region is AT-rich (73%), and
contains two possible polyadenylation/transcrip-
tion termination signals TAG...TAGT...TTT at
positions 812 and 844 [10],
3.3. Comparison of DNA and protein sequences
A comparison of the amino acid sequence
deduced from the DNA sequence with that deter¬
mined by manual Edman degradation of pro¬
teolytic fragments of the protein [5] reveals several
discrepancies (fig.2). Some of the differences
probably relate to S. cerevisiae strain differences.
The phosphoglycerate mutase used for the protein
sequencing and X-ray crystallography was purified
from dried baker's yeast, and was genetically
heterogeneous as indicated by sequence micro-
heterogeneities between residues 139 and 166 [5],
The sequence differences between residues 46 and
52 may indicate an additional heterogeneous
region. The occurrence of sequence heterogeneities
complicated the protein sequence determinations,




Fig.l. Restriction map of YEpl3-GPM and sequencing strategy
of GPM gene. The thick lines indicate the phosphoglycerate
mutase coding sequence. Arrows show the direction and length
of individual sequence determinations. Restriction enzymes:
Hindlll (H), Sail (S), FcoRI (E), Bglll (B), BomHI (Ba), Xhol
(X) and Atul (A).
tion of the Asp-Leu sequence (residues 169—170).
The other sequence discrepancies can be explained
in terms of difficulties inherent in the manual Ed-
man degradation procedure. For example, the
amide assignments were largely based on the elec-
trophoretic mobilities of peptides, and residue 99
was incorrectly assigned as glutamine because of
the abnormally low pK of His-88. The interchange
of the serine and valine residues at positions 172
and 176 resulted from having missed the labile
serine residue after Edman degradation. Similarly,
the sequence between residues 207 and 210 involves
an incompletely cleaved proline and a labile
threonine. The determination of the sequence of
the C-terminal portion of the protein relied heavily
384








15 EK NLFTGWVDVK LSAK GQQE 34
105 GCCGCTAGAGCCGGTGAATTGTTGAAGGAAAAGAAGGTCTACCCAGACGTCTTGTACACT 164
35 AARAGELLKEKKVYPDVLYT 54
G N V L D
165 TCCAAGTTGTCCAGAGCTATCCAAACTGCTAACATTGCTTTGGAAAAGGCTGACAGATTA 224
55 SK LSRA I QT AN I ALEK A D R L 74
225 TGGATTCCAGTCAACAGATCCTGGAGATTGAACGAAAGACATTACGGTGACTTACAAGGT 284








155 I DRLLPYWQDV I AK DLLSGK 174
- - V
525 ACCGTCATGATCGCCGCTCACGGTAACTCCTTGAGAGGTTTGGTTAAGCACTTGGAAGGT 584













Fig.2. Nucleotide sequence and deduced amino acid sequence of GPM gene. The underlined sequences are discussed in the text.
Residues different in the published protein sequence [5] are indicated below the deduced amino acid sequence, and are discussed in
the text.
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on overlapping peptic peptides, and the unusually
large number of alanines between residues 232 and
239 (7 of 8 residues) was incorrectly identified. The
presence of a glutamine at position 243 reduced the
efficiency of Edman degradation, and the order of
the C-terminal three residues was largely assigned
on the basis of the complete resistance of this
region to digestion by carboxypeptidases A, B and
Y.
3.4. Comparison with mammalian phospho-
glycerate mutases
Phosphoglycerate mutase exists as three dif¬
ferent isoenzymes in mammalian tissues: type M
T v^jv
10 20
A H B | L | V | M | V | E ■ G I
HI SKYKL I NLRNQB
KK 3BYELIHLRHOB










■ N B F C
B H B F C


























D A E N
A L M F




20 30 40 50
Y V L Y T S E L 8 R A T 9
HM I C Y T 8 V L E R A I R
HE L V P T 8 V L N R 8 I ■







1 HI1-3<] E A D R L W I P V N R
A I L|D G T D 9 N W L P V V R
L I L B E L G 9 E W V P V E S
L 1 L E E L G E W V P V E S
70 80
|3W BLMEBHYO







B K Q N
BEEN
100
1 10 120 130 140
120 I 30 TT5~
Y E F | G E 1 |E F N T YjR R S F O V P P P P I D A 8 S{P] F S 9 E G D E|R Y D P N V L P R T E 8
m e H G E R Q V R 8 W R R 8 F D I P P P P H D E E M P Y Y N S I 8 E E R R Y A G L E P G R L P T C E 8
HE N H G B E Q V R L W R R S Y N V T P P P I E B 8 ■ P Y Y 9 R I Y M D R R Y E V C D V P L D 9 L P R 8 E S




L E D V









I A E D L|TJS






G E R V L I
GET I L I





A 3 G K S L R G v SBLEGISD A V A
A H G N 8 L R G I V erlbg|h|sd 9 *1' N
A H G N S 8 R A L L E H L B G 1 8 D E D I I







L P T G
L P T O










e lIn e e l
E L D E N L
ELDER L
20
E P 8 E P
E P T E P
R A V O P
R A V G P
230
B A |A A|X G A A A












V A M 9 O E E
V A A 9 G E A E
V E D 9 9 E V E 9 A E E
V E D 9 O E V E_ BABE
50
Fig.3. Comparison of amino acid sequences of yeast and mammalian phosphoglycerate mutases. The sequences are taken from the
following references: human muscle phosphoglycerate mutase (HM) [14], human erythrocyte phosphoglycerate mutase (HE) [15],
rabbit erythrocyte phosphoglycerate mutase (RE) [16] and fructose 2,6-bisphosphatase (FP) [13]. The numbering along the top of the
sequences refers to the yeast sequence, and that below to the erythrocyte sequences. The boxed-in residues show the regions that are
identical in three or more sequences. Gaps have been introduced in the Y and HM sequences to maximise homology.
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predominates in muscle, type B in brain and type
E in erythrocytes. The E type enzyme catalyses the
synthesis and breakdown of 2,3-bisphospho-
glycerate (2,3-BPG), in addition to catalysing the
interconversion of 2- and 3-phosphoglycerates.
This isoenzyme is frequently known as bisphos-
phoglycerate mutase, and plays a major role in
regulating haemoglobin oxygen affinity as a conse¬
quence of controlling 2,3-BPG concentration. A
comparison of the sequence of yeast phospho-
glycerate mutase with the sequences of M and E
type mammalian phosphoglycerate mutases is
given in fig.3. These enzymes show the same slow
rate of evolution as observed for other glycolytic
enzymes [11], with about half of the residues iden¬
tical between the yeast and mammalian enzymes.
The two mammalian isoenzymes are as divergent
from each other (49% different) as they are from
the yeast enzyme, implying that the E isoenzyme
experienced a period of rapid change after the gene
duplication of an ancestral mutase gene before it
settled down to the slow rate of change shown by
a comparison of the rabbit and human E isoen¬
zymes (3.5% different).
Most, but not all, of the active-site residues [4]
are conserved. Thus, His-8 (yeast numbering) and
His-181 which are involved in phospho transfer
and Arg-59 which is required for binding the car-
boxyl group of the phosphoglycerates are identical
in all sequences. However, Ser-11 and Thr-20
which in the yeast enzyme probably provide
ligands for binding the transferred phospho group
are not conserved. The replacement of Ser-11 by a
glycine in the E isoenzyme is consistent with the
greater instability of its phosphorylated form [12],
and also with the relative ease with which the
product 2,3-BPG can dissociate [1]. The replace¬
ment of Thr-20 by a cysteine explains why muscle
but not yeast phosphoglycerate mutase is inhibited
by thiol modifying reagents (review [11]).
The sequence of an active-site peptide from rat
liver fructose 2,6-bisphosphatase has recently been
reported, and its homology with the active site of
phosphoglycerate mutases noted [13] (see fig.3).
Like the mutases, fructose 2,6-bisphosphatase in¬
volves a phosphohistidine intermediate (His-8 of
the yeast mutase), and the sequence similarities in¬
dicate that the enzymes have probably diverged
from a common ancestor.
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